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Abstract 
 
 p-Cymene based ruthenium complexes were employed in the alkylation of t-
butylamine with phenethyl alcohol by redox neutral alkylation  and in the reduction of 
acetophenone and benzaldehyde by transfer hydrogenation. A range of in situ generated 
catalysts formed by [RuX2(p-cymene)]2 dimers (X=Cl or I) with dppf, DPEPhos, dippf or P(i-
Bu)3 and a range of p-cymene ruthenium monomers, namely [RuCl(dppf)(p-cymene)]SbF6, 
[RuI(dppf)(p-cymene)]SbF6, [RuCl(dppf)(p-cymene)]BF4, [RuCl(dppf)(p-cymene)]Cl, [RuI(P(n-
Bu)3)2(p-cymene)]SbF6, [RuCl(P(i-Bu)3)2(p-cymene)]SbF6, [RuCl2(P(n-Bu)3)2(p-cymene)], 
[RuCl(P(CH3)3)2(p-cymene)]SbF6 have been employed in these reactions. These monomers 
have been synthesised and characterized in this project and only [RuCl2(P(n-Bu)3)2(p-
cymene)] has been already reported in the literature. 
Results were compared in terms of conversions and the best ones for the redox 
neutral alkylation were with the in situ generated catalyst formed by [RuI2(p-cymene) and  
DPEPhos, giving 96% conversion for a catalyst/substrate ratio of 20 and with [RuI(dppf)(p-
cymene)]SbF6 which gave 85% conversion for a catalyst/substrate ratio of 40. These 
reactions have been run out in the open air without degassing or inert gas protection 
throughout which is not the typical approach found in the literature and that can be very 
appealing in the industrial point of view. The different halides incorporated in these 
complexes have been proved to have different effects in the catalytic activity, with iodine 
usually leading to more active catalysts. Some results and experiments that were performed 
allowed drawing some conclusions about the mechanism.  
For the reduction of acetophenone and benzaldehyde by transfer hydrogenation it 
has been demonstrated that the dimers, the dimer-phosphine pairs and the ruthenium 
monomers mentioned before are not the most suitable pre-catalysts for these reactions. 
Overall, conversions up to 73% were obtained which lag far behind the 100% reported in the 
literature for several other complexes. Some conclusions were drawn about the mechanism 
and two catalytic cycles were proposed. 
The brand new dimer [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 has been serendipitously 
synthesised and has shown it forms catalytically active species in both the alkylation of t-
butylamine and reduction of acetophenone giving moderate conversions. 
Keywords: transfer hydrogenation, ruthenium, p-cymene, N-alkylation, catalyst. 
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Resumo 
 
Neste projecto foram sintetizados complexos de ruténio e p-cimeno que foram 
posteriormente avaliados do ponto de vista catalítico em reacções de transferência de 
hidrogénio. Os complexos de ruténio e p-cimento têm demonstrado ser catalisadores/pré-
catalisadores eficientes em várias reacções envolvendo compostos orgânicos e foi 
inicialmente sugerido para este projecto pela empresa biofarmacêutica Astra Zeneca o 
estudo da actividade catalítica do dímero [RuCl2(p-cimeno)]2 na presença das fosfinas  
DPEPhos, dippf e P(i-Bu)3 em reacções de transferência de hidrogénio. Esta empresa 
verificou que este dímero é extremamente activo na alquilação de morfolina com álcool 
benzílico na presença das fosfinas referidas (conversões acima de 97%).  
No que respeita aos complexos sintetizados, levaram-se a cabo as sínteses dos 
dímeros de cloro e iodo de fórmula molecular [RuX2(p-cimeno)]2 em que X = Cl ou I e ainda 
de monómeros utilizando os dímeros referidos como compostos de partida. A síntese do 
dímero de bromo foi também tentada mas este revelou-se muito difícil de obter e portanto 
não foi utilizado em sínteses posteriores nem nas reacções catalíticas. Para obter os 
monómeros foram ainda utilizadas fosfinas mono ou bidentadas, nomeadamente dppf, 
DPEPhos, dippf, P(i-Bu)3, P(n-Bu)3, P(CH3)3 ou PhPCl2 que originaram os seguintes complexos 
neutros ou mono catiónicos:  [RuCl(dppf)(p-cimeno)]SbF6, [RuI(dppf)(p-cimeno)]SbF6, 
[RuCl(dppf)(p-cimeno)]BF4, [RuCl(dppf)(p-cimeno)]Cl, [RuCl(P(n-Bu)3)2(p-cimeno)]SbF6, 
[RuI(P(n-Bu)3)2(p-cimeno)]SbF6, [RuCl(P(i-Bu)3)2(p-cimeno)]SbF6, [RuCl2P(n-Bu)3(p-cimeno)], 
[RuCl2P(i-Bu)3(p-cimeno)], [RuCl(P(CH3)3)2(p-cymene)]SbF6 e [RuCl2PPh(OCH3)2(p-cymene)]. 
Entretanto foi ainda sintetizado, por acaso, o dímero [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 numa 
das tentativas de obter o monómero [RuCl(DPEPhos)(p-cymene)]SbF6. Estes compostos 
foram caracterizados por 1H, 13C e 31P NMR, espectrometria de massa e análise elementar. 
Entre eles apenas os complexos neutros [RuCl2P(n-Bu)3(p-cimeno)] e [RuCl2P(i-Bu)3(p-
cimeno)] já tinham sido referenciados na literatura.  
 As reacções aos quais foram submetidos os complexos sintetizados envolvem todas 
elas, como foi dito, transferência de hidrogénio. Este tipo de reacções envolve normalmente 
a redução de cetonas ou iminas e a oxidação de álcoois ou aminas em que um catalisador 
transfere hidrogénio entre entre o substrato e o dador ou aceitador de hidrogénio, 
respectivamente. As reacções de transferência de hidrogénio que aqui foram testadas foram 
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a alquilação da t-butilamina com álcool feniletílico designada formalmente por “redox 
neutral alkylation” e a redução da acetofenona e do benzaldeído aos respectivos álcoois. O 
potencial catalítico dos complexos sintetizados para com as reacções mencionadas foi 
avaliado maioritariamente por 1H NMR pela percentagem de álcool de partida convertido a 
produto e num dos casos foi avaliado por cromatografia gasosa pela monitorização da 
concentração de produto ao longo do tempo. Nomeadamente  foi avaliado o potencial 
catalítico dos dímeros, dos dímeros na presença de fosfinas e dos monómeros.  
Na alquilação da t-butilamina os dímeros por si mesmo revelaram-se inapropriados 
uma vez que não foram obtidas conversões acima de 3%. Já no caso dos dímeros na 
presença de fosfinas os resultados foram significativamente melhores com o par [RuCl2(p-
cimeno)]2-DPEPhos a merecer lugar de destaque uma vez que apresentou 96% de álcool de 
partida convertido a produto com uma proporção substrato/catalisador de 20. Este 
resultado foi mesmo o melhor de entre todas as reacções de alquilação levadas a cabo. 
Relativamente ao uso dos monómeros como pré-catalisadores, o monómero [RuI(dppf)(p-
cimeno)]SbF6 apresentou o resultado mais promissor com 85% de conversão com uma 
proporção substrato/catalisador de 40. Estes resultados tornam-se ainda mais interessantes 
se levarmos em conta de que estas reacções  foram levadas a cabo em contacto com a 
atmosfera, sem desarejamento ou uso de gás inerte durante a reacção o que não é a 
abordagem normalmente encontrada na literatura e que pode ser muito apelativa do ponto 
de vista industrial. De uma maneira geral as fosfinas bidentadas levaram a resultados 
promissores tanto quando usadas em combinação com os dímeros tanto quando foram 
incorporadas nos respectivos monómeros. O mesmo não pode ser dito das fosfinas 
monodentadas. A fosfina P(i-Bu)3 quando na presença do dímero [RuCl2(p-cimeno)]2 levou a 
uma conversão de álcool a amina de apenas 28% e quando incorporada no respecivo 
monómero [RuCl(P(i-Bu)3)2(p-cimeno)]SbF6 não foi além dos 9%. Os outros complexos 
contendo fosfinas monodentadas e que foram testados nesta reacção de alquilação, 
nomeadamente o [RuI(P(n-Bu)3)2(p-cimeno)]SbF6, [RuCl2P(n-Bu)3(p-cimeno)], e o 
[RuCl(P(CH3)3)2(p-cymene)]SbF6 não formaram qualquer espécia activa cataliticamente uma 
vez que não foi detectada a formação de qualquer amina. Nesta reacção, para além da 
análise do efeito da fosfina, foi analisado o efeito do halogeneto e de uma maneira geral a 
presença de iodo em vez de cloro tanto nos dímeros como nos monómeros levou à 
obtenção de maiores precentagens de produto e/ou redução na quantidade de álcool por 
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reagir. Foi ainda analisado o efeito do contra-ião, nomeadamente entre os monómeros 
[RuCl(dppf)(p-cimeno)]SbF6, [RuCl(dppf)(p-cimeno)]BF4 e [RuCl(dppf)(p-cimeno)]Cl e o 
monómero [RuCl(dppf)(p-cimeno)]Cl parece ser o melhor pré-catalisador apresentando 82% 
de amina obtida com uma proporção substrato/catalisador de 20. Os resultados sugerem 
ainda que os complexos de fórmula molecular [RuX(LL)(p-cimeno)]+ onde X = halogeneto e LL 
= ligando bidentado são os precursores catalíticos nas reacções em que são empregues os 
dímeros [RuX2(p-cimeno)]2 e fosfinas bidentadas. 
Uma das reacções de alquilação, como dito anteriormente, foi monitorizada por 
cromatografia gasosa. Nesta reacção foi empregue o dímero [RuCl2(p-cimeno)]2 na presença 
de dppf e a monitorização decorreu durante 24h, isto é, o tempo a que todas as alquilações 
foram submetidas. No entanto esta reacção apresentou concentrações de produto/ 
conversões muito abaixo das esperadas comparativamente à conversão obtida por 1H NMR 
para a mesma reacção. Apesar disso, o padrão de redução da concentração de álcool e o 
padrão de aumento da concentração de produto ao longo do tempo, corroboram uma das 
observações feitas acerca das conversões obtidas por 1H NMR, nomeadamente de que 
durante a reacção se está a formar um produto secundário, nomeadamente o éster 
PhCH2CH2O2CCH2Ph que resulta da reacção do aldeído formado cataliticamente com o álcool 
remanescente em solução que ainda não reagiu. No entanto, dadas as incoerências 
encontradas a nível das concentrações, da avaria do cromatógrafo gasoso durante um largo 
período de tempo e de algumas questões relacionadas com o método, a monitorização por 
cromatografia gasosa foi abandonada. 
Relativamente às reduções por transferência de hidrogénio, nomeadamente a 
redução da acetofenona e do benzaldeído estas demonstraram padrões de conversão muito 
semelhantes, nomeadamente os pré-catalisadores que apresentaram percentagens de 
conversão maiores foram os dímeros sem qualquer adição de fosfina, ao contrário do que 
aconteceu nas reacções de alquilação, e a presença de iodo nos pré-catalisadores não levou 
ao aumento, na grande maioria dos casos, da percentagem de produto obtido. No geral, não 
foram obtidas conversões acima de 73% o que é um resultado que fica muito aquém dos 
100% já referenciados na literatura para uma larga gama de complexos. Ainda, mais uma 
vez, as fosfinas monodentadas parecem não ser apropriadas para serem incorporadas nos 
pré-catalisadores nas reacções de transferência de hidrogénio uma vez que o monómero 
[RuI(P(n-Bu)3)2(p-cimeno)]SbF6 não foi além dos 3% de acetofenona convertida ao respectivo 
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álcool ou além dos 12% no caso do benzaldeído. Apesar de tudo, os resultados obtidos 
permitiram especular um pouco acerca dos mecanismos reaccionais seguidos tendo sido 
propostos dois mecanismos, um para quando são empregues apenas os dímeros e outro 
para quando são empregues os dímeros na presença de fosfinas ou empregues os 
monómeros. 
 Quanto aos resultados obtidos pelo dímero [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6, este 
formou espécies activas cataliticamente tanto nas alquilações como nas reduções obtendo-
se conversões moderadas em ambos os casos, o que não deixa de ser um resultado 
interessante uma vez que, tanto quanto se sabe, ainda não foi referenciado na literatura o 
uso de complexos com três pontes de cloro nas reacções em questão. 
 
Palavras-chave: transferência de hidrogénio, ruténio, p-cimeno, N-alquilação, catalisador. 
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1. Introduction 
 
1.1 Aims 
 
This project is concerned about the synthesis and evaluation of the catalytic 
properties of p-cymene ruthenium (II) complexes towards a series of organic and 
pharmaceutical reactions of great industrial interest. These reactions are redox neutral 
alkylations and transfer hydrogenations. Both of them are applications of the transfer 
dehydrogenation/hydrogenation methodology. Hydrogen transfer reactions are mild 
methodologies for reduction of ketones or imines and oxidation of alcohols or amines in 
which a substrate-selective catalyst transfers hydrogen between the substrate and a 
hydrogen donor or acceptor, respectively.2 This methodology is increasing its importance 
and growing rapidly since it is contributing to more selective chemical processes with a 
minimum amount of waste (“green chemistry”). Unlike typical hydrogenations, it does not 
involve the use of molecular hydrogen which is explosive and the handling requires 
expensive and specialized equipment. Also, hydrogen gas is highly reactive, therefore 
showing low chemoselectivity towards other functional groups.3  
 The organometallic approach of using a molecular catalyst consisting of a metal atom 
or ion, phosphorus or nitrogen donor ligands and η6-arenes is the general approach for the 
purpose of the reactions mentioned above and it was the approach followed herein. These 
complexes are believed to have catalytic potential due to spectator benzene-substituted ring 
which provides steric protection for the ruthenium centre by blocking three adjacent 
coordination sites in an octahedral Ru coordination environment, leaving three sites with a 
fac relationship for other functions.4 The ligands employed in this project were η6-arenes, 
phosphines and halides. The ruthenium chemistry is based on previous work in the 
McGowan’s research group. 
 
1.2 Target molecules for catalysis 
 
The complexes used/synthesized in this project were η6-arenes ruthenium 
derivatives, where the ruthenium centre adopts a half-sandwich structure. Complexes with 
p-Cymene Based Ruthenium Complexes as Catalysts 
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such structure are widely known as piano-stool complexes and are, without doubt, the most 
studied ones within the large family of η6-arene ruthenium complexes.  This family of 
complexes possess a pseudo-octahedral geometry at the ruthenium (II) atom where the 
arene ligand occupies three coordinating sites (the seat) and the other ligands (the legs) 
occupies the other three places (figure 1.1). The coordinated aromatic ring introduces steric 
 
Ru
XL
L
LL = diphosphines or 
2 monodentate phosphines
X = halides
 
 
Figure 1.1 – Coordination sites for ligands in piano-stool complexes. 
 
and electronic properties, for instance it prevents the metal centre from being rapidly 
oxidised to ruthenium (III).5 These properties linked to those of the corresponding co-
ligands, affect reactivity and if the one of the ligands is chiral, it affects mainly the 
enantioselectivity, and this is higher with substituted arenes, for example, than with simple 
benzene.6 Modifications in the arene moiety, for instance the introduction of different 
substituents, provide ruthenium complexes with different solubility, reactivity, biological 
activity, immobilization potential, among others. These modifications can be achieved since 
the complexation of aromatic ligands by transition metal has a great effect on the reactivity 
of the arene. One major feature is the enhancement of the acidity of benzylic protons, which 
could lead to the alkylation and functionalisation of the methylated aromatic compounds. 
Arene ligands are relatively inert towards substitution reactions and consequently are often 
considered as spectator ligands.5 
The other three coordinating sites available in the ruthenium complexes and are 
opposite to the arene ligands can be used to introduce a wide variety of ligands with N-, O-, 
S- or P-donor atoms.7 The resulting complexes are neutral, mono- or dicationic, and often 
these ligands are labile.  In this project some monodentate and bidentate P-donor ligands 
(phosphines) were studied in catalytic reactions. Phosphine ligands have the general formula 
p-Cymene Based Ruthenium Complexes as Catalysts
PR3 where R = alkyl, aryl, H, halide etc., and are neutral two electron donors that bind to 
transition metals through their lone pairs. A variety of chiral phosphine transition metal 
complexes have been reported in the literature
stereogenic and can function as stereospecific catalysts. Phosphines are easy to synthesise 
and are considered as excellent ligands for transition metals. As a 
attributes of the phosphine ligand are easily controlled. This ability to control the bulk of the 
ligand permits one to tune the reactivity of the metal complex. For example, if the 
dissociation of a phosphine ligand is the first st
accelerated by utilizing a larger phosphine ligand. Likewise, if dissociation is a problem, then 
a smaller phosphine can be used. The bonding in phosphine ligands, like that of carbonyls 
can be thought of as having two
donation of the phosphine lone pair to an empty orbital on the metal. The second 
component is backdonation from a filled metal orbital to an empty orbital on the phosphine 
ligand (figure 1.2). This empty phosphorous orbital has been described as being either a d
orbital or an antibonding sigma orbital; current consensus is that the latter is more 
 
Figure 1.2 – Components of bonding in phosphine ligan
 
appropriate given the relatively high energy of a phosphorous d
withdrawing (electronegative) groups are placed on the phosphorous atom, the sigma
donating capacity of the phosphine ligand tends to decrease. At the same time, the energy 
of the pi-acceptor (sigma-*) on phosphorous is lowered in energy, providing an increase in 
backbonding ability. Therefore, phosphines can exhibit a range of sigma donor and pi
acceptor capabilities, and the electronic properties of a metal centre can be tuned by th
substitution of electronically different but isosteric phosphines. 
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Besides the coordinate phosphines, a third coordination position still available in the 
piano-stool complexes can be filled with halides. Indeed, halide ions are among the most 
common ligands found on transition metal catalysts and most of the available catalysts or 
pre-catalysts that can be found in the market are halo-complexes.9 Halides play the role of 
spectator or ancillary ligands in transition metal ligand-substitution reactions. Since most of 
the reactions with halo-complexes involve the removal of halides from the coordination 
sphere and replacement with weakly coordinating anions, halide ligands are often regarded 
as being of limited importance. Although, through a wise choice of the ancillary ligands it is 
often possible to alter the steric and electronic properties (influence both reactivity and 
selectivity) of the metal and therefore influence the course of many catalytic reactions. 
In reactions where the halide is cis to the reaction, the relative size of the halide can 
influence the easiness of the process. For example, as the steric bulk of a ligand increases, 
oxidative addition process can be slowed while reductive elimination may be favoured as 
means of reducing the steric interactions. The steric bulk of halide ligands increase down the 
group in terms of ionic radii, covalent radii, and cone angle. On the other hand, 
electronegativity increases up the group. Due to this electronegativity profile and availability 
of the s electrons, the ability to form σ bonds increases down the group (figure 1.3). In the  
 
 
 
Figure 1.3 – Electronic properties of halide ligands. 
 
absence of other interactions, iodide is expected to form the strongest bonds and donate 
the most electron density to the metal. This is rarely the case, however, since π interactions 
commonly occur between the halide lone-pair electrons and the metal d orbitals. When π 
interactions predominate, the opposite trend in electron donation to that predicted by 
electronegativity can be observed, and fluorine is the strongest π donor. π interactions occur 
when there is a metal orbital of appropriate symmetry available to interact with  halide lone 
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pairs. If this orbital is empty, a net stabilization can result. If the d orbital is fully occupied, a 
net destabilization termed “filled-filled” interactions will occur (figure 1.4).  
 
 
Figure 1.4 – Stabilization and destabilization arising from molecular orbital interactions for an 
octahedral coordination geometry. 
 
Another halide feature that should be mentioned is the polarizability. Halides relative 
polizaribility or softness is expected to increase down the group. It can be expected that as a 
transition metal becomes softer in character it will increasingly prefer to bind the heavier 
halides (other ligands present in the complex can influence this trend). Transition metals will 
become softer in character as its oxidation state is lowered, the further down the group it 
lies, and the further to the right in the transition metal series it is found.    
 
1.3 Ligand Effects in Catalysis 
 
 Arene ruthenium complexes were shown to be catalytically active in hydrogenation, 
transfer-hydrogenation, Diels-Alder reactions, olefin metathesis, olefin cyclopropanation, 
atom-transfer radical polymerisation and kinetic resolutions.5 In most cases, the ruthenium 
catalyst precursor possesses a hydrocarbon η6-arene ligand with nitrogen or phosphorus 
donor ligands. In general, the catalytic activities and selectivity are good and are strongly 
affected by the nature of the arene ligand.10 In most cases the mechanism of these catalytic 
reactions remains a debatable point, and the role of the arene ligand is unclear. For instance, 
in the transfer hydrogenation of ketones, the arene moiety is assumed to be a spectator 
ligand, while for olefin metathesis and atom-transfer radical polymerisation, the catalytic 
activity results from arene displacement. Therefore, in some cases it is crucial to form a 
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robust molecular arene ruthenium catalyst to avoid arene exchange, while in other cases 
arene displacement is an essential step in the catalytic cycle. 
Arene ruthenium compounds were employed as catalysts in asymmetric synthesis. 
The three-legged piano-stool complexes with three different ligands possess metal-centred 
chirality and some research groups are using the arene ligand to introduce a second element 
of chirality, thus giving rise to diastereoisomers instead of enantiomers which are difficult to 
resolve. The first strategy is to use planar chirality as a second element of chirality while the 
second possibility is to introduce an enantiomerically pure auxiliary group tethered to the 
arene ligand. 
 Apart from the aromatic ring, also halides have been reported as playing a significant 
role in some catalytic reactions. For example, D. Gillingham et. al. reported that the 
ruthenium iodide complex shown in figure 1.5 promotes ring-opening metathesis with 
significantly higher asymmetric induction than the chloride analogue, although being less 
active.11 They attempted the reaction with the chiral iodide complex depicted in figure 1.5 in 
order to obtain higher optical purity, what came to be true. They were inspired by a 
disclosure by Grubbs who reported that addition of NaI to a solution of a chiral Ru-dichloride 
phosphine complex in certain cases leads to enhancement in enantioselectivity of ringclosing 
metathesis. 
 
 
Figure 1.5 – Ruthenium complexes with different catalytic effects. 
 
Phosphine ligands complexes of late transition metals have been widely used in 
almost every kind of C–H, C–C, and C–X bond-forming reactions, most notably asymmetric 
hydrogenation (Ru, Rh, Ir) and palladium catalysed processes.12 Many of the phosphine 
ligands developed for hydrogenation reactions also generate high selectivity over a broad 
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canvas of mechanistic unrelated reactions, and were subsequently termed as “privileged” 
ligands (figure 1.6). This has stimulated further development of ligands that contain similar 
structure elements. 
 
 
 
Figure 1.6 – “Privileged” phosphine ligands in catalysis. 
 
  
1.4 Ruthenium catalysts and Ruthenium Catalysed Reactions 
 
Ruthenium has been playing a crucial role in catalysis. It is a widely used metal centre 
for catalytic complexes, employed in many different types of catalytic reactions at small and 
industrial scales. The reason for this is the large number of advantages that this metal 
presents. Since it has 4d75s1 electron configuration, it has the widest scope of oxidation 
states of all elements of the periodic table, varying from -2 in complexes like Ru(CO)4
2- to +8 
in, for example, RuO4, and each of these oxidation states has a preferred coordination 
geometry, like trigonal-bipyramidal or octahedral for Ru(0), (II) and (III) respectively.13  
Ruthenium complexes have a variety of useful characteristics including high electron 
transfer ability, high Lewis acidity, low redox potentials and stabilities of reactive metallic 
species such as oxometals, metallacycles, and metal carbene complexes. Since many of them 
are air and moisture stable, they can be prepared easily at ambient conditions, frequently 
using RuCl3⋅nH2O as the starting material. Thus, a large number of novel, useful reactions 
have begun to be developed using both stoichiometric and catalytic amounts of ruthenium 
complexes. 
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Ruthenium complexes have increased their importance in organic synthesis over the 
years. They have been used in reduction, oxidation, isomerisation and carbon-carbon bond 
formation. Some examples of reduction and oxidation reactions are shown bellow. 
In reductions, ruthenium complexes have been used successfully in hydrogenations 
employing or not molecular hydrogen. Low-valent ruthenium complexes are excellent 
catalysts for these reactions because of their low redox potential and higher affinity toward 
heteroatom compounds. Ru-BINAP complexes serve as efficient catalysts for the asymmetric 
hydrogen transfer reactions of α,β-unsaturated carboxylic acids with formic acid (scheme 
1.1). Combined use of ruthenium complexes with chiral amine ligands is proven to be highly 
effective for enantioselective synthesis. 
 
 
Scheme 1.1 – Enantioselective synthesis employing a ruthenium catalyst with a chiral ligand.  
 
Ruthenium complexes have also been successfully employed in oxidations. One of 
the typical oxidations is the transformation of primary alcohols to the corresponding esters 
(scheme 1.2). These reactions are initiated by the oxidative addition of O-H bond of alcohols 
to low-valent ruthenium complexes and the subsequent β-hydrogen elimination. 
 
 
Scheme 1.2 – Oxidation of an alcohol to an ester employing a ruthenium catalyst. 
 
Low-valent ruthenium complexes also catalyze the oxidation of alcohols and the related 
hydroxy compounds in combination with various oxidants such as t-BuOOH, AcOOH, H2O2 
etc. (scheme 1.3). 
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Scheme 1.3 – Oxidation of an alcohol employing a ruthenium catalyst and an oxidant. 
 
1.5 Reactions of Interest for this Project 
 
The target catalytic reactions of this project are transfer hydrogenations and redox 
neutral alkylations. These reactions are of great interest to the pharmaceutical industry and 
to the chemical industry in general because they allow: the obtainment of compounds 
otherwise not possible to obtain synthetically; an easiest (cheaper) way to obtain 
compounds already available in the market; and, on the other hand, they are considered as 
“green” technology since, usually, the by-products are harmless to the environment (e. g. 
water).  
All the reactions that are being considered have several features in common, like all 
of them use similar transition metal catalysts composed by the metal and coordinating 
ligands and all of them proceed, in principle, through hydrogenations/dehydrogenations of 
ketones-alcohols, imines-amines or both, without the use of molecular hydrogen.14 These 
reactions are known as transfer hydrogenations where hydrogen atoms are transferred 
between an organic substrate and a hydrogen acceptor or donor. This occurs upon 
coordination of these molecules to the metal catalysts employed and they can proceed 
through different pathways. Bäckvall and co-workers2 conclude that for transition metals, 
routes involving the formation of a hydride intermediate are by far the most common. In 
some of these reactions, hydride intermediates have already been isolated. 
Transfer hydrogenation using alcohol as the hydrogen source is a convenient method 
to reduce ketones and imines because of the simplicity in experimental aspects. In this 
project were studied the reductive transfer hydrogenation of acetophenone and aldehyde. 
The advantages of hydrogen transfer over other methods of hydrogenation comprise the use 
of readily available hydrogen donors such as isopropanol, the very mild reaction conditions, 
and the high selectivity15 (scheme 1.4).  
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Scheme 1.4 – Hydrogenation and transfer hydrogenation of carbonyl compounds using either the 
formic acid/triethylamine or isopropanol as hydrogen source. 
 
In fact, isopropanol has been widely used in transfer hydrogenations. Employment of this 
solvent which is not toxic and is easy to handle requires an excess of alcohol to shift the 
equilibrium to the desired product.16 This alcohol has been chosen instead of primary 
alcohols like ethanol or methanol since it has a more favourable redox potential. 
Furthermore, the aldehydes resulting from primary alcohols are susceptible in basic media to 
deprotonation of the hydrogens of the α-CH group which leads to aldol condensation and 
may also undergo decarbonylation reactions with deactivation of the catalysts.15 It is well-
documented that the presence of a strong base as a cocatalyst enhances the rate of these 
reactions.17  
 Hydrogen transfer reactions have been used together with other reactions. Due to 
their reversibility, they have been exploited extensively in racemisation reactions in 
combination with kinetic resolutions of racemic alcohols.15 This resulted in the so called 
dynamic kinetic resolutions, kinetic resolutions of 100% yield of the desired enantiopure 
compound. Hydrogen transfer reactions were also incorporated in reactions called redox 
neutral alkylations which were also studied in this project and are described later. 
 The interest over transfer hydrogenations has increased over time. The fact that 
contributed the most to this was the application of this methodology together with chiral 
catalysts in the dehydrogenation of prochiral ketones which allowed the obtainment of 
alcohols in high enantiopure form. This transformation is known as asymmetric transfer 
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hydrogenation (ATH) and has recently been the subject of intense study by a number of 
groups worldwide.18 It is among the most important transformations to prepare alcohols in 
high enantiopure form from ketones (scheme 1.5). Among small chiral molecules, chiral 
alcohols occupy a central place in the synthesis of pharmaceuticals, flavour, aroma and 
agricultural chemicals, and speciality materials.19 
 
 
 
Scheme 1.5 – General scheme for the asymmetric transfer hydrogenation of ketones using 
isopropanol as hydrogen donor. The resulting by-product is a molecule of acetone. 
 
 The major contribution to ATH was provided by Noyori et. al.,20 who reported highly 
active and robust Ru(II) catalysts based on complexes of monotosylated diamines and amino 
alcohols in the decade of 90. Generally, the reaction rate and the enantioselectivity are 
dependent on the electronic properties of the substituents on the aromatic ring as well as 
the steric environment of the carbonyl group21. It has also been reported that reactions 
proceed faster with electron-withdrawing groups in the substrates, and this has been 
explained in terms of molecular orbitals, with lower LUMO values giving faster reactions.22, 23 
Since ATH is an operational simple and versatile reaction, it has become one of the best 
reduction systems for both academia and industry.18 
 Redox neutral alkylations or N-alkylations are reactions that convert primary amines 
into secondary or tertiary amines using alcohols as alkylating agents.24 Amines are of 
significant importance for the bulk and fine chemical industry as building blocks for 
polymers, dyes, but also for the synthesis of new pharmaceuticals and agrochemicals.25 
Previous methodology used alkyl halides as alkylating agent but it can give rise to poly-
alkylation products and is unpleasant for the environment because alkyl halides can be toxic 
and generate wasteful salts as by-products.26 Another well-known method which has been 
developed as the most useful tool in the synthesis of various amines is the reductive 
amination of aldehydes and ketones. But, because it requires the use of strong reducing 
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agents or dangerous hydrogen gas, is not the best one to follow. Also this method is not 
always selective for monoalkylation of primary amines. The N-alkylation of amines with 
alcohols proceeds via a hydrogen borrowing strategy24 (scheme 1.6). This strategy combines 
the advantages of transfer hydrogenation with additional transformations. The hydrogen 
donor compound is not a waste compound such as isopropanol. Initially the alcohol borrows 
the hydroxilic proton to the catalyst and forms a carbonyl compound (oxidation by transfer 
hydrogenation), then the carbonyl compound reacts with the primary amine to give an 
imine, which is then converted to the final amine by reductive amination with the hydrogens 
borrowed by the alcohol through the catalyst.  
The alkylation of amines by alcohol occurs with loss of water and has been proved to 
be a thermodynamically favored process where the loss of a C-O bond for a C-N bond is 
compensated by the gain of an O-H bond for an N-H bond.1 
 
 
Scheme 1.6 – Borrowing Hydrogen Strategy in the alkylation of amines with alcohols.27 
 
The first homogeneous catalysts for N-alkylation of amines with alcohols were 
introduced by Grigg et. al.28 and Watanabe et. al.29 in the early 1980s. Grigg and co-workers 
described the N-alkylation of primary and secondary alkyl amines with primary alcohols such 
as methanol or ethanol with the rhodium catalyst [RhH(PPh3)4] being the most active. 
Watanable and co-workers reported the ruthenium-catalyzed N-alkylation of aniline with 
primary alcohols with [RuCl2(PPh3)3]. There have been several ruthenium
30-33 and iridium34-36 
catalysts reported subsequently. Many of these catalysts require forcing conditions which 
prevents their use with sensitive substrates. However, Yamaguchi and co-workers26 have 
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already employed milder conditions with Cp*IrCl2 as well as Beller‘s group using Ru3(CO)12 
with bulky phosphines.37 
 The most active catalysts for these reactions have been proved to be those of 
iridium, like [Ir(COD)Cl]2 (COD = cyclooctadiene) or [Cp*IrI2]2, but ruthenium has also been 
used due to more accessible costs.6 
 Recently, J. Williams et. al.24 have reported a high efficient in situ ruthenium catalyst 
consisting of [Ru(p-cymene)Cl2]2 and dppf for the N-alkylation of amines with primary 
alcohols. The reaction conditions are relatively mild and applicable to the alkylation of aryl 
amines as well as cyclic aliphatic amines such as pyrrolidine (scheme 1.7)1, 24. 
 
 
Scheme 1.7 – Ruthenium-catalyzed N-alkylation of amines with primary alcohols by J. Williams et. al. 
showing the reaction yields.1 
 
As seen, N-allkylation is a very attractive method because (1) the overall reaction is 
atom efficient consuming all of the starting material; (2) it does not generate harmful by-
products (only H2O) and (3) alcohols are environmentally benign as well as more readily 
available than corresponding halides or carbonyl compounds in many cases.26, 27 Although 
these reactions have been frequently applied, there is no catalytic method available for 
functionalized and sensitive substrates (alcohols and amines) under milder conditions (<100 
˚C). It was because of this fact that this project was carried out in order to look for more 
active catalysts which allow a broader substrate scope. 
 
1.6 Mechanistic Features Common to the Reactions of Interest 
 
Several studies have been carried out in order to understand the mechanistic 
pathway in hydrogen transfer reactions. The reactions mentioned before use transition 
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metal catalysts and Bäckvall and co-workers, despite not having entirely elucidate the 
mechanisms, have summarized some common features for these metals.2 They found that 
routes involving the formation of a hydride intermediate are by far the most common. Such 
hydrides have indeed been isolated from transition metal-catalyzed hydrogen transfer 
reactions in some cases (figure 1.7). 
 
 
Figure 1.7 – Examples of metal hydrides that have been isolated or proven to take place in hydrogen 
transfer reactions. 
 
 Hydrogen transfers to ketones (aldehydes) are supposed to occur mainly by two 
pathways. Either by a hydridic route for transition metals as said before or by a direct 
hydrogen transfer that is thought to be the main pathway for main group metals. Indeed, 
the later pathway was one of the first approaches to reactions like transfer hydrogenations. 
It consists in the Meerwein-Ponndorf-Verley (MPV) reduction of ketones by alcohols or the 
reverse reaction, the Oppenauer oxidation. It is proposed to proceed through a six-
membered transition state ring as shown in figure 1.8.  
 
O
H
O
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Figure 1.8 – Original version of the MPV reduction. Direct hydrogen transfer through an aluminium 
alkoxide using isopropanol reported in the early XX century.2 
 
 Due to the drawbacks of scaling up the MPV, namely the aluminium salt is often 
required in stoichiometric amount,17 there has been an increased interest in catalytic 
hydrogen transfer reactions. This led to the discovery of the catalytic activity of transition 
metals which were found to work via a hydridic route. Some research groups2, 38-40 have 
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suggested that there are two possible main pathways for this route. It proceeds either by a 
dihydride or monohydride mechanism which will depend both on the metal employed and 
the ligands coordinated to that metal in the catalytic complex.  Experimentally, it was found 
that while rhodium and iridium catalysts favor the monohydride route, the mechanism for 
ruthenium catalysts proceeds by either pathway depending on the ligands. Deuteration 
experiments are usually carried out to find out the route for each case. In the dihydride 
mechanism both hydrogens from C-H and O-H in the hydrogen donor are transferred to the 
metal as hydrides (scheme 1.8) whereas in the monohydride mechanism only the C-H 
hydrogen from the donor enters in the coordination sphere that way (scheme 1.9).  The 
monohydride mechanism followed depends on both the catalyst and substrate and the 
classical is the one involving a metal alkoxide as intermediate.2 This path is known as Inner-
sphere pathway (scheme 1.10). 
 
 
 
Scheme 1.8 – Racemisation of an α-deuterated chiral alcohol in the dihydride mechanism.2  
 
 
 
Scheme 1.9 – Racemisation of an α-deuterated chiral alcohol in the monohydride mechanism.2 
 
 
Scheme 1.10 – Inner-sphere pathway for monohydride mechanisms.2 
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After formation of the metal alkoxide by direct coordination of the alcohol to the metal, β-
elimination takes place to give the metal hydride. However, this mechanism is thought of not 
being the most likely to occur in catalysts that contains a basic centre in one of their ligands. 
In these catalysts the basic center interacts by means of a hydrogen bond with the protic 
hydrogen from the donor, while the hydrogen in the carboxylic carbon bonds to the metal 
forming a six-membered transition state which promotes the hydride formation (scheme 
1.11). So there is a simultaneous transfer of a proton to the metal and to the ligand without 
prior coordination of the substrate to the metal. This is a monohydride outer-sphere 
mechanism and an example of that is the so called Noyori’s metal ligand bifunctional 
catalysis. The full catalytic cycle is outlined in Scheme 1.12.19 It proceeds in a concerted 
manner, but outer-sphere mechanisms can also occur in two discrete steps, where the 
protonation of the substrate precedes the hydride transfer.2 
 
 
 
Scheme 1.11 – Outer-sphere concerted pathway for monohydride mechanisms.2 
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Scheme 1.12 – ATH of ketones by isopropanol via Noyori’s metal–ligand bifunctional catalysis.19  
 
 
In the Noyori’s metal ligand bifunctional catalysis, Noyori employed chelating ligands 
with NH2 groups like N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine to form complexes 
like [RuCl(η6-arene)TsDPEN]. In this complex, the NH2 group of the TsDPEN ligand needs to 
be treated with a base to achive deprotonation and form the active species (scheme 1.12). 
These complexes proved to be highly efficient in asymmetric transfer hydrogenations.20  
The presence of a strong base like NaOH or KOH is usually a pre-requisite for 
bifunctional catalysis. This fact represents a drawback from an industrial point of view due to 
corrosion, possible negative effects in stereoselectivity and cannot be used for base-
sensitive substrates. It has been demonstrated by Carrión and co-workers that hydrogen 
transfer hydrogenations can proceed without employing any base when ligands are of the 
type NN.41 They found possible the decoordination of the NN ligand and formation of an 
unsaturated species, which can first allow the coordination of alcohol forming an alkoxide to 
give a ruthenium hydride by β-elimination (inner-sphere pathway) and then the coordination 
of the substrate to be hydrogenated (scheme 1.13). 
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Scheme 1.13 – Mechanism for the hydride formation in the catalytic transfer hydrogenation of 
ketones under base-free conditions proposed by Carrión et. al.41 
 
2. Results and Discussion 
 
2.1 Target Molecules with Regard to Catalytic Studies 
 
The initial target molecules of this project are complexes with the formula 
[RuX2(η
6-cymene)]2, this is dihalide(p-cymene)ruthenium(II) dimers. These molecules are 
intended to be the precursors for possible ruthenium catalysts of the reactions under 
investigation. The reason to start with these p-cymene dimers is that the chlorine dimer 
[RuCl2(p-cymene)]2 (1) has been proved to be effective in the catalytic processes of interest 
for the project and has been widely used to synthesise p-cymene based ruthenium 
complexes which show promising catalytic potential. Different halides were incorporated in 
these complexes. Their different relative lability is expected to have different implications on 
the relative activity of these complexes. This is because the catalytic reactions of interest for 
this project are supposed to proceed via the formation of a ruthenium hydride complex, 
which would require the dissociation of a labile pre-existing ligand. Both the chlorine and 
iodine dimers, [RuCl2(p-cymene)]2 (1) and [RuI2(p-cymene)]2 (2) respectively, are 
commercially available but their syntheses are relatively simple. [RuCl2(p-cymene)]2 (1) was 
chosen as the starting material to try to obtain [RuBr2(p-cymene)]2 (3) and [RuI2(p-cymene)]2 
(2) since it is the easily available one. Previous methods reporting the synthesis of the 
[RuCl2(p-cymene)]2 (1) include those of Bennett et al.
42
 and M. Spicer et al.43 The synthesis of 
[RuI2(p-cymene)]2 (2) and [RuBr2(p-cymene)]2 (3) has been reported by C. Hartinger and co-
workers44. 
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The catalytic properties of these dimers in the presence of the phosphine ligands 
(dippf, DPEPhos and PiBu3) selected by Astra Zeneca
45 (biopharmaceutical company) were 
evaluated mainly by 1H NMR by the calculation of the percentage of conversion into the 
catalytic product. Some gas chromatography (GC) studies were attempted in order to 
monitor the reactions (% of conversion over time) but due to several complications not 
many results were obtained. The effect of different halides and different phosphine ligands 
in catalysis was evaluated. Some new ruthenium half-sandwich complexes were synthesised 
and the same studies were performed. 
 
2.2 Synthesis of the Ruthenium Precursors [RuX2(p-cymene)]2 (X=Cl, Br, I) 
 
[RuCl2(p-cymene)]2 (1) had already been synthesised within the McGowan’s group 
with a procedure adapted from those cited before.46 This procedure was optimized and used 
in this project. The dimer was obtained in 92% yield by a reaction between 4-methyl-1-(1-
methylethyl)-1,3-cyclohexadiene (α-Terpinene) and RuCl3.3H2O in reflux of ethanol (scheme 
2.1).   Elemental analysis and mass spectrometry results matches to what is expected. 
 
Ru
Cl
Cl
Ru
Cl
+
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RuCl3.3H2O
Cl
 
Scheme 2.1 – Synthesis of [RuCl2(p-cymene)]2 (1). 
 
To synthesise [RuI2(p-cymene)]2 and [RuBr2(p-cymene)]2 it can be used RuI3 and RuBr3 
as start materials but these ruthenium (III) complexes are expensive, so the following halide 
exchange reactions were carried out (scheme 2.2):  
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Scheme 2.2 – Synthesis carried out to obtain [RuI2(p-cymene)]2 (2) and [RuBr2(p-cymene)]2  (3).  
 
The synthesis of [RuI2(p-cymene)]2 (2) and [RuBr2(p-cymene)]2 (3)  was already 
attempted within the McGowan’s group by A. Rodríguez.6 [RuI2(p-cymene)]2 (2) was 
obtained in a good yield (80%) by reacting [RuCl2(p-cymene)]2 (1) with NaI in acetone under a 
nitrogen atmosphere,14 according to a procedure that uses iridium instead of ruthenium.47 
The microcrystalline product was characterized by 1H NMR and elemental analysis and was 
compared with the literature44 which confirmed the product formation. In the literature44 it 
is reported the synthesis of [RuI2(p-cymene)]2 (2) using the respective potassium salt (KI) and 
water/chloroform. They obtained a dark violet solid in 67% yield. These same two 
procedures were attempted before to obtain [RuBr2(p-cymene)]2 (3)  but none of them were 
successful. In the first one (NaBr in acetone) a not clear 1H NMR spectrum of the orange 
product was obtained and, if present, only 26% yield was achieved. In the second procedure 
(KBr in water/chloroform) again the 1H NMR was not clear and no yield was calculated. 
 In this project, some other reactions were attempted by varying the solvent and the 
halide salt in order to obtain a better yield and a better product characterization. Reactions 
with the salts KI (dark violet color, 58% yield), NaBr (brown color, mixture of products) and 
KBr (red color, mixture of products) were attempted in acetone. In water/chloroform 
reactions was attempted the use of NaI (dark violet color, 91% yield), NaBr (orange color, 
53%), KBr (orange color, 31%) and LiBr (orange color, 31%). LiBr and HBr in THF were also 
employed in the synthesis of [RuBr2(p-cymene)]2 (3) as suggested by a paper of Süss-Fink and 
co-workers48 but the starting material was obtained after all.  
Summarizing, the best results of the synthesis of [RuI2(p-cymene)]2 (2)  and [RuBr2(p-
cymene)]2 (3) were in water/chloroform employing NaI and NaBr respectively. [RuI2(p-
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cymene)]2 (2) was obtained in very good yield (91%) and 
1H NMR is very clear with all the 
signals being shifted (mainly downfield) compared to those of [RuCl2(p-cymene)]2 (1) (figure 
2.1). The color is different as well; [RuI2(p-cymene)]2 (2) is a very dark violet, almost black 
solid, while [RuCl2(p-cymene)]2 (1) is red. [RuBr2(p-cymene)]2 (3) was obtained in 53% yield 
(orange), but the 1H NMR peaks have the same chemical shift as [RuCl2(p-cymene)]2 (1) 
peaks. The only difference is that they are broadened. To conclude more about this fact, 
[RuCl2(p-cymene)]2 (1) was added to the NMR tube containing [RuBr2(p-cymene)]2 (3) and it 
was observed that the height of the peaks has increased, however the broadness has 
remained. It suggests that [RuBr2(p-cymene)]2 (3) is actually a mixture of [RuBr2(p-cymene)]2 
(3) and [RuCl2(p-cymene)]2 (1) and the amount of [RuCl2(p-cymene)]2 (1) added just increased 
the amount of it in the mixture. 
Full characterization data for compounds [RuCl2(p-cymene)]2 (1), [RuI2(p-cymene)]2 
(2) and [RuBr2(p-cymene)]2 (3) can be found in the experimental section. 
1H NMR spectra of 
these three compounds are shown in figure 2.1 and a labelled diagram of complex 1 in figure 
2.2. In table 2.1 is found the 1H NMR chemical shift assignment for 1. 
 
6 4 2 0
Chemical Shift (ppm)
6 4 2 0
Chemical Shift (ppm)
6 4 2 0
Chemical Shift (ppm)
( 1 )
( 2 )
( 3 )
 
Figure 2.1 – 1H NMR spectra of [RuCl2(p-cymene)]2 (1), [RuI2(p-cymene)]2 (2) and [RuBr2(p-cymene)]2 
(3) in CDCl3. 
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Figure 2.2 – Labelled diagram of [RuCl2(p-cymene)]2 (1) for 
1H NMR purposes. 
 
 
Table 2.1 – 1H NMR chemical shift assignment of [RuCl2(p-cymene)]2 (1). 
Chemical Shift, δ (ppm) 1H Assignment 
5.48 (d, 4H) c, c’ 
5.35 (d, 4H) b, b’ 
2.93 (sept, 2H) d 
2.17 (s, 6H) a 
1.29 (d, 12H) e, e’ 
 
Protons b & b’ and c & c’ are not chemically equivalent and consequently the p-cymene 
ligand exhibits a quadruplet AB which integrates to 8H. 
 NMR spectroscopy allowed distinguishing [RuCl2(p-cymene)]2 (1) from [RuI2(p-
cymene)]2 (2), but not from [RuBr2(p-cymene)]2 (3). Also, elemental analysis and mass 
spectrometry agreed with what is expected for [RuCl2(p-cymene)]2 (1) and [RuI2(p-cymene)]2 
(2) but not for [RuBr2(p-cymene)]2 (3). These results associated with the fact that different 
exchange reactions led to different shades of orange when trying to get [RuBr2(p-cymene)]2 
(3) suggests that those reactions led to a mixture of both [RuCl2(p-cymene)]2 (1) and 
[RuBr2(p-cymene)]2 (3) which could not be separated.  This difficulty in its preparation may 
be related with solubility issues, where the formation of NaCl from NaBr may not be 
favoured. [RuBr2(p-cymene)]2 (3) was found to be successfully synthesised by G. Süss-Fink 
and co-workers48 who reacted [Ru2(p-cymene)2Cl2(µ-H)] with hydrobromic acid, but this 
method has not been tried in this project. Because of these issues with the synthesis of 
[RuBr2(p-cymene)]2 (3) it was not used in further synthesis/catalytic reactions.   
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Complexes [RuCl2(p-cymene)]2 (1) and [RuI2(p-cymene)]2 (2) present similar 
solubilities and stability. Both of them are soluble in common solvents and are air stable.  
Water solubility is negligible.  
 
2.3 Synthesis of p-cymene ruthenium monomers 
 
Some half-sandwich ruthenium complexes containing phosphine ligands were 
synthesised for the first time in order to test them as catalysts and conclude something 
about the mechanistic features. These complexes are important in the immobilization point 
of view for heterogeneous catalysis. A complex like that is often called a ruthenium 
monomer and is supposed to be formed and act as the actual pre-catalyst in reactions where 
dimers and for example a phosphine ligand like dppf are employed in one-pot reactions.24 
This idea comes from the metal ligand bifunctional catalysts developed by Noyori, 
specifically from the [RuClTsDPEN(p-cymene)] complex, which was proven to be formed in 
the catalytic reaction between [RuCl2(p-cymene)]2 and TsDPEN ligand to act as the actual 
pre-catalysts in asymmetric transfer hydrogenations. The intermediates have been isolated 
and their structures determined by X-ray crystallography.19, 49, 50 The phosphine ligands that 
were employed in the catalytic reactions together with the dimers in this project were 
incorporated in some of these monomers so it is possible to compare the activity of the 
monomers to the one of the dimers. The focus was also to synthesise complexes with 
different counter-ions since it is expected that ruthenium complexes with larger, less 
coordinating anions should prove to be more effective as catalysts. This fact has already 
been proved by S. Lord51 from the McGowan’s group in the hydrogenation of acetophenone 
employing ruthenium half-sandwich complexes with picolinamide and p-cymene ligands. 
This fact will be now verified in N-alkylations. 
 
2.3.1 Synthesis of [RuCl(dppf)(p-cymene)]SbF6 (4) 
 
The synthesis of [RuCl(dppf)(p-cymene)]SbF6 (4) was attempted by two different 
methods. The second one was attempted after the first one since it is simpler and gave good 
results when attempted before with other compounds. 
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2.3.1.1 Method 1 
 
[RuCl(dppf)(p-cymene)]SbF6 (4) was synthesised as shown in scheme 2.3. After 
stirring the chlorine dimer in a mixture of methanol-acetonitrile and NaSbF6, dppf ligand in 
THF was added (1:2:2 molar ratio) and left stirring at room temperature. It was recrystallised 
from a mixture of ethanol and acetone to afford a brownish orange powder in 29% yield. 
This procedure was adapted from the protocol of synthesis of [RuCl(dppf)(p-cymene)]PF6, 
this is complex 4 but with PF6
- as counter-ion, reported by W. Kaim et. al.52 Syntheses of the 
same compound (with PF6
-) were after reported by M. Spicer and co-workers43 and Y. 
Yamamoto et. al.53 Compound 4 as far as it is known has not been synthesised before, is air 
and moisture stable, cationic 18-electron complex and was characterized by 1H, 13C{1H} and 
31P{1H} NMR, mass spectrometry and elemental analysis. The NMR studies that were done 
for compound 4 were sort of extensive since not that detailed NMR assignments were 
reported before in the literature for structure related compounds like [RuCl(dppf)(p-
cymene)]PF6
43, 52, 53, [RuCl(dppf)(η5-Cp)]54 or [(p-Cymene)Ru(μ-Cl)3RuCl(dppf)]
55. 
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Scheme 2.3 – Synthesis of [RuCl(dppf)(p-cymene)]SbF6 (4). 
 
2.3.1.1 Method 2 
 
The method here attempted was based in the synthesis of p-cymene picolinamide 
ruthenium half-sandwich complexes reported by S. Lord51 from the McGowan’s group. 
[RuCl2(p-cymene)]2 (1) dissolved in methanol, was treated with dppf in the presence 
of NaSbF6 in a 1:2:2 molar ratio at room temperature to precipitate an orange powder in 
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79% yield without the need of further purification. The product was only characterized by 1H 
NMR. 
 
2.3.1.2 1H, 13C{1H} and 31P{H} NMR characterization for [RuCl(dppf)(p-
cymene)]SbF6 (4) 
 
The following characterization was done with [RuCl(dppf)(p-cymene)]SbF6 (4) 
synthesised by method 1. A labelled diagram of compound 4 is shown in figure 2.3. Spectral 
assignments for this compound are found in table 2.2. The 1H NMR spectrum, 13C{1H} NMR 
spectrum and two partial HMQC spectra are shown in figures 2.5, 2.6 and 2.7, respectively.  
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Figure 2.3 – Labelled diagram of [RuCl(dppf)(p-cymene)]SbF6 (4)  for NMR purposes. 
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Table 2.2 – 1H and 13C{1H} NMR chemical shift assignment of [RuCl(dppf)(p-cymene)]SbF6 (4) in 
(CD3)2CO. 
Chemical Shift, δ (ppm) 1H Assignment Chemical Shift, δ (ppm) 
13 1
Assignment 
7.87 (m, 4H) j,j’ or m,m’ 139.55 (‘t’, 2C) 13 or 17 
7.78 (m, 2H) l or o 136.24 (t, 4C) 14,14’ or 18,18’ 
7.72 (m, 4H) k,k’ or n,n’ 134.92 (‘t’, 2H) 13 or 17 
7.72 (m, 4H) j,j’ or m,m’ 134.41 (t, 4C) 14,14’ or 18,18’ 
7.52 (m, 2H) l or o 132.97 (s, 2C) 16 or 20 
7.50 (m, 4H) k,k’ or n,n’ 131.61 (s, 2C) 16 or 20 
6.12 (broad s, 2H) g,g’ or f,f’  129.40 (t, 4H) 15,15’ or 19,19’ 
5.52 (d, 2H) g,g’ or f,f’ 129.20 (t, 4H) 15,15’ or 19,19’ 
5.06 (s, 2H) a, b, c or d 100.08 (s, 1C) 7 or 10 
4.49 (s, 2H) a, b, c or d 97.29 (‘t’, 2C) 
 
8,8’ or 9,9’ 
 4.40 (s, 2H) a, b, c or d 91.77 (t, 2C) 
 
8,8’ or 9,9’ 
 4.21 (s, 2H) a, b, c or d 84.84 (‘t’, 1C) 
 
5 
 2.75 (m, 1H) h 79.36 (t, 1C) 
 
1, 2, 3 or 4 
 1.05 (s, 3H) e 75.81 (t, 1C) 1, 2, 3 or 4 
 0.88 (broad s, 6H) i,i’ 74.60 (t, 1C) 1, 2, 3 or 4 
   70.24 (t, 1C) 1, 2, 3 or 4 
   31.65 (s, 1C) 11 
  21.00 (s, 2C) 12,12’ 
  14.95 (s, 1C) 6 
 
The characteristic feature of the 1H NMR spectrum (figure 2.5) is the presence of four kinds 
of protons in the range from δ 4.21 to 5.06 ppm, four sharp singlets corresponding to the Cp 
rings, which show the inequivalency of these protons. The Cp of the dppf group normally 
displays two signals in the 1H NMR. This inequivalence comes from the rigid ferrocene 
moiety upon chelation of the dppf ligand,53 as depicted in figure 2.4. The Cp rings are 
chemically equivalent.  13C{1H} NMR of these rings gave five signals, four of them are very 
well defined triplets corresponding to the CH groups and another one, an “irregular shape 
triplet” (figure 2.6, expansion at 84.84 ppm), corresponding to the quaternary carbon. These 
triplets arise from the coupling of the phosphorus and ruthenium atoms to the 13C nuclei. 
Heteronuclear NMR spectroscopy (HMQC-correlation 1H-13C{1H}) helped in the assignment 
of p-cymene and Cp peaks since they appear in the same region of the NMR spectrum (figure 
2.7b). COSY experiments were also important in the assignment of the p-cymene peaks. 
DEPT 13C NMR experiments were useful in the assignment of the quaternary carbons. 
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Figure 2.4 – Crystal structure of [RuCl(dppf)(p-cymene)]PF6 reported by M. Spicer et. al.
43 The ligand 
phenyl protons and PF6 are omitted for clarity. 
 
The phenyl protons appeared in the 1H NMR spectrum as a group of four multiplets where is 
possible to assign six different signals with the help of HMQC (figure 2.7a). Three of those 
signals correspond to the ortho, meta and para protons of 2 equivalent phenyl rings and the 
other three to the other two phenyl rings. In the 13C{1H} NMR it is possible to observe four 
peaks to each pair of equivalent phenyl rings (2). Two of these peaks are triplets and 
corresponds to the ortho and meta carbons. The para carbons come as a singlet and the 
quaternary ones as an “irregular shape triplet”. The different multiplicity of these aromatic 
peaks is due to the distance to the phosphorus atom, not occurring any coupling in the case 
of the furthest carbons (para). 
The 31P{1H} NMR spectrum showed a single singlet at δ 37.78 ppm which represents 
the chemical equivalence of the phosphorus atoms. This fact corroborates with the chemical 
equivalence of the Cp rings and the existence of two pairs of equivalent phenyl groups as 
said before in the 1H and 13C{1H}  NMR analysis. Mass spectrum and elemental analysis are in 
agreement to what is expected for the proposed structure. 
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Figure 2.5 – 1H NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) in (CD3)2CO with expansions of the 
Cp and p-cymene peaks. 
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Figure 2.6 – 13C{1H} NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) in (CD3)2CO with expansions of 
the phenyl, Cp and p-cymene peaks. o= ortho, p = para, m= meta, q = quaternary carbon. 
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Figure 2.7 – Expansions of HMQC NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) in (CD3)2CO.  a) 
phenyl protons region. b) Cp and aromatic p-cymene protons region. 
 
2.3.2 Synthesis of [RuI(dppf)(p-cymene)]SbF6 (5) 
     
[RuI(dppf)(p-cymene)]SbF6 (5) was synthesised according to the synthesis of 
[RuCl(dppf)(p-cymene)]SbF6 (4) but using [RuI2(p-cymene)]2 (2) as the starting material 
instead of [RuCl2(p-cymene)]2 (1). As in compound 4, it was also recrystallised from a mixture 
of ethanol and acetone and a brownish red solid was obtained in 12% yield. RuI(dppf)(p-
cymene)]SbF6 (5) is air and moisture stable, cationic 18-electron compound. It was 
characterized by 1H, 13C{1H} and 31P{1H} NMR, mass spectrometry and elemental analysis. 
The later analysis differs from the expected. For example, for the iodine it was found 22.45% 
whereas the calculated percentage is 11.01. Despite of this, mass spectrum shows the 
correct molecular peak at m/z 917.0 which corresponds to [M] – SbF6. The 
1H NMR pattern 
for this compound, although quite similar to the analogous [RuCl(dppf)(p-cymene)]SbF6 (4), 
has a feature that allows distinguishing both. As shown for [RuI2(p-cymene)]2 (2), with this 
iodine complex there was again a significantly downfield shift of the aromatic p-cymene 
peaks and also the CH peak from the CH(CH3)2 group when compared to those of the 
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corresponding chlorine version [RuCl(dppf)(p-cymene)]SbF6 (4). The latter peak was also the 
one that suffered the biggest shift which suggests that this proton should be the one closer 
to the iodine atom.  
 
2.3.3 Synthesis of [RuCl(dppf)(p-cymene)]BF4 (6) 
 
Method 2 of synthesis of [RuCl(dppf)(p-cymene)]SbF6 (4) was followed but this time 
AgBF4 was used instead of NaSbF6.  [RuCl2(p-cymene)]2 (1), dissolved in methanol, was 
treated with dppf in the presence of the salt. The precipitation of a white powder (NaCl) 
occurred instead of the product. The product was precipitated from chloroform by diethyl 
ether. [RuCl(dppf)(p-cymene)]BF4 (6) is a yellow, air and moisture stable, cationic 18-electron 
compound which was obtained in 33% yield. It was characterized by 1H, 13C{1H} and 31P{1H} 
NMR, mass spectrometry and elemental analysis.  Elemental analysis results are not the best 
for the chlorine content (5.40 % found against 3.89 % calculated) which is thought to be 
related with possible NaCl still present in the solid obtained. Further washings with water 
might have helped.  
 
2.3.4 Synthesis of [RuCl(dppf)(p-cymene)]Cl (7) 
  
The synthesis of [RuCl(dppf)(p-cymene)]Cl (7) was based in the synthesis of the 
analogous [RuCl(p-cymene)(Me-Duphos)]Cl reported by P. Pregosin et. al.56 Two molar 
equivalents of dppf ligand and one molar equivalent of [RuCl2(p-cymene)]2 (1) were reacted 
in a mixture of ethanol and benzene (scheme 2.4). Solvents were removed under reduced 
pressure. The resulting residue was dissolved in dichloromethane and diethyl ether 
precipitated a light orange product. It was recrystallized from methanol-diethyl ether and 
characterized by 1H and 31P{1H} NMR, mass spectrometry and elemental analysis. All these 
techniques match to what is expected for the proposed structure. 
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Scheme 2.4 – Synthesis [RuCl(dppf)(p-cymene)]Cl (7). 
 
If a comparison is made between the structures of [RuCl(dppf)(p-cymene)]SbF6 (4), 
RuCl(dppf)(p-cymene)]BF4 (6) and [RuCl(dppf)(p-cymene)]Cl (7) it comes immediately that 
the only difference lies in the counter-ion. So, it is expected that the NMR spectra are quite 
similar. In fact, the 1H NMR shifts (in CDCl3) are almost exactly the same for the same peaks 
in the different compounds. But, there is a peak that can tell the difference between these 
structures. It is the aromatic p-cymene proton peak most downfield shifted (assigned with 
an “X” in figure 2.8). From compound 4 (SbF6 counter-ion) to 6 (BF4) there is a downfiled 
shift of 0.11 ppm and from 4 to 7 (Cl counter-ion) of 0.21 ppm. This fact allows 
differentiating these compounds without the need of elemental analysis.  
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Figure 2.8 – 1H NMR spectra of compounds [RuCl(dppf)(p-cymene)]SbF6 (4), [RuCl(dppf)(p-
cymene)]BF4 (6) and [RuCl(dppf)(p-cymene)]Cl (7) in CDCl3. X = p-cymene peak that undergoes 
shifting according to the different counter-ion of the complex. 
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2.3.5 Synthesis of [Ru2(CH3CN)2(DPEPhos)2]SbF6 (8) 
 
[Ru2(CH3CN)2(DPEPhos)2]SbF6 (8) was synthesised in an attempt to obtain 
[RuCl(DPEPhos)(p-cymene)]SbF6. The same methodology as [RuCl(dppf)(p-cymene)]SbF6 (4) 
(acetonitrile/methanol solvent system) was followed but instead of using dppf, DPEPhos was 
used as the phosphine ligand. Instead of obtaining the monomer, a trichloro-bridged dimer 
containing two DPEPhos and two acetonitrile molecules was the product. p-Cymene 
displacement has occurred. The product was recrystallised twice, the first time from ethanol 
and the second time from methanol to afford a pale yellow solid in 10% yield. It was 
characterized by 1H, 13C{1H} and 31P{1H} NMR, mass spectrometry and elemental analysis. 
The results from these techniques are in agreement with the proposed structure. Structure 
related compounds have been previously reported in the literature employing different 
methods of synthesis. For example, the more similar ones [Ru2Cl3(PP)2(MeCN)2]PF6 (PP= 
dppb or diop, X=Cl or PF6) were prepared from RuCl4(PP)2 or RuCl2(PP)(PPh3)
57
.
 
 
2.3.5.1 X-ray crystal structure analysis of complex 8 
 
The molecular structure of [Ru2(NCCH3)2(DPEPhos)2]SbF6 (8) can be seen in figure 2.9. 
Yellow needles suitable for X-ray crystallography were obtained by vapour diffusion of 
pentane into a saturated solution of the complex in chloroform. Complex 8 crystallised in a 
monoclinic cell and structural solution was performed in the space group P21/c. The 
coordination about each Ru center is distorted octahedral. Complex 8 is face-sharing 
bioctahedra, containing two metal centres bridged by three chloride ligands. The average 
Ru-Cl bond length is 2.478 Å, which is comparable with the corresponding average Ru-Cl 
bond length (2.483 Å) in the related structure compound [Ru(dcypb)(CO)]2(μ-Cl)3]Cl,
58 where 
dcypb=1,4-bis(dicyclohexylphosphino)butane. Also bond angles fall within the same values 
as those of [Ru(dcypb)(CO)]2(μ-Cl)3]Cl (crystal data, labelled molecular structure and selected 
bond lengths and angles of [Ru2(NCCH3)2(DPEPhos)2]SbF6 (8) are in appendixes 16, 17 and 18, 
respectively).  
 
p-Cymene Based Ruthenium Complexes as Catalysts
Figure 2.9 – Molecular 
crystallography in this project
 
2.3.6 Synthesis of
 
In the literature it is
[RuCl(η6-C6H6)P(n-Bu3)2]Cl 
arene ligand and different 
cymene)]SbF6 (4) was followed.
Starting with [RuCl2
phosphine ligand, tri-n-butylphosphine,
can be seen in scheme 2.5
chloroform and pentane to afford crystalline orange clusters.
cymene)]SbF6 (9) is an air stable, cationic 18
yield. Although air stable it is not stable in 
observed (gets darker/ brown) after one or two days. Also the
increase in the number of peaks.
spectrometry and elemental analysis which 
Joel David Avelino Fonseca 
 
structure of [Ru2(NCCH3)2(DPEPhos)2]SbF6 (8
. 
 [RuCl(P(n-Bu3))2(p-cymene)]SbF6 (9)                      
 possible to find the synthesis of the structure related compound 
reported by P. Pregosin et. al.56 However, 
counter-ion so the method 2 of synthesis of 
  
(p-cymene)]2(1), SbF6
- was used in methanol
 was employed in excess. The general synthetic route 
. After filtering the NaCl formed, the product was obtained from 
-electron compound which was obtained in 13% 
CDCl3 solutions since a change in color 
 1H NMR spectrum suffers 
 It was characterized by 1H, 13C{1H} and 
are in agreement with the proposed structure.
 
33 
 
) obtained by X-ray 
 
it has a different  η6-
[RuCl(dppf)(p-
 as counter-ion .The 
 [RuCl(P(n-Bu3))2(p-
was 
an 
31P{1H} NMR, mass 
 
p-Cymene Based Ruthenium Complexes as Catalysts 
34 
Joel David Avelino Fonseca 
Ru
Cl
Cl
Ru
Cl
Cl
CH3OH
NaSbF6
P(n-Bu)3
Ru
P
P Cl
SbF6
 
Scheme 2.5 – Synthesis of [RuCl(P(n-Bu3))2(p-cymene)]SbF6 (9). 
 
2.3.7 Synthesis of [RuI(P(n-Bu3))2(p-cymene)]SbF6 (10)      
 
[RuI(P(n-Bu3))2(p-cymene)]SbF6 (10) was obtained according to the synthesis of 
[RuCl(P(n-Bu3))2(p-cymene)]SbF6 (9) but [RuCl2(p-cymene)]2(1) was used as the starting 
material instead of [RuI2(p-cymene)]2(2). After filtering the NaCl formed, a red wine color 
powder was precipitated from chloroform by diethyl ether. [RuI(P(n-Bu3))2(p-cymene)]SbF6 
(10) is an air stable, cationic 18-electron compound which was obtained in 48% yield. As 
[RuCl(P(n-Bu3))2(p-cymene)]SbF6 (9), it is not very stable in CDCl3 solutions. It was 
characterized by 1H, 13C{1H} and 31P{1H} NMR, mass spectrometry and elemental analysis. 
The later analysis differs slightly from the expected but, as in [RuI(dppf)(p-cymene)]SbF6 (5), 
mass spectrum shows the correct molecular peak at m/z 767.3 which corresponds to [M] – 
SbF6.  
 
2.3.8 Synthesis of  [RuCl(P(i-Bu3))2(p-cymene)]SbF6 (11)      
 
[RuCl(P(i-Bu3))2(p-cymene)]SbF6 (11) was synthesised according to the same method 
(reagents and quantities) as [RuCl(P(n-Bu3))2(p-cymene)]SbF6 (9), which means phosphine 
ligand in excess as well. But in this synthesis the white precipitate was not readily formed. 
After obtaining the yellow product by precipitation from chloroform with diethyl ether, it 
was washed with diethyl ether and water to remove NaCl and afford fine yellow needles. 
[RuCl(P(i-Bu3))2(p-cymene)]SbF6 (11) (figure 2.10) is an air stable cationic 18-electron 
compound and as [RuCl(P(n-Bu3))2(p-cymene)]SbF6 (9), it is not very stable in CDCl3 solutions.  
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It was characterized by 1H, 13C{1H}  and 31P{1H}  NMR, mass spectrometry and elemental 
analysis which are in agreement with the proposed structure. 
  
Ru
P
P Cl
SbF6
 
Figure 2.10 – Molecular structure of [RuCl(P(i-Bu3))2(p-cymene)]SbF6 (11). 
 
2.3.9 Synthesis of [RuCl2P(i-Bu3)(p-cymene)] (12) 
 
This monosubstituted monomer was actually obtained in an attempt to synthesise 
the disubstituted one [RuCl(P(i-Bu3))2(p-cymene)]SbF6 (11). Scheme 2.5 was followed but no 
excess of phosphine was employed (scheme 2.6). Two molar equivalents of phosphine to 
one molar equivalent of ruthenium were used. A brown solution was obtained and the 
solvent was evaporated under reduced pressure. The resulting residue was dissolved in 
chloroform and a layer of pentane added and left in the freezer overnight. Both a brownish 
red powder and a yellow powder were obtained. After NMR and mass spectrometry analysis 
it was possible to conclude that the brownish red powder was the monosubstituted 
monomer [RuCl2P(i-Bu3)(p-cymene)] (12) and the yellow one the disubstituted [RuCl(P(i-
Bu3))2(p-cymene)]SbF6 (11). The brownish red powder was recrystallized from acetone and 
was characterized by 1H NMR, mass spectrometry and elemental analysis which are in 
agreement with the proposed structure. [RuCl2P(i-Bu3)(p-cymene)] (12) is an air stable, 
neutral 18-electron compound and as [RuCl(P(n-Bu3))2(p-cymene)]SbF6 (9), it is not very 
stable in CDCl3 solutions.  No yield was calculated but by looking at the amount obtained, it 
was low. This compound has been previously synthesised by S. Nolan and co-workers.59 
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Scheme 2.6 – Synthesis of [RuCl2P(i-Bu3)(p-cymene)] (12). 
 
2.3.10 Synthesis of [RuCl2P(n-Bu3)(p-cymene)] (13)                 
   
This monosubstituted complex was obtained according to scheme 2.5 but without 
employing any NaSbF6 and any excess of phosphine ligand P(n-Bu3). One molar equivalent of 
phosphine per one molar equivalent of ruthenium was used. After removing the solvent 
under reduced pressure, the solid was dissolved in chloroform and precipitated with diethyl 
ether. [RuCl2P(n-Bu3)(p-cymene)] (13) is a red air stable, neutral 18-electron compound 
which was obtained in 60% yield. It was characterized by 1H NMR and mass spectrometry 
which are in agreement with the proposed structure. This compound has been previously 
synthesised by Bennett and co-workers.60 
 
2.3.11 Synthesis of [RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) 
 
This complex disubstituted with P(CH3)3 ligand was synthesised according to scheme 
2.5. The phosphine ligand was employed in excess. A white precipitate was formed and 
filtered. The product was obtained from chloroform by precipitation with diethyl ether. 
[RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) is a yellow air stable, cationic 18-electron compound 
which was obtained in 26% yield. It was characterized by 1H and 31P{1H} NMR and mass 
spectrometry which are in agreement with the proposed structure. Elemental analysis was 
also performed but the percentages are slightly deviated from the calculated values. 
[RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) with PF6
- as counter-ion instead of SbF6
-
 has been 
previously reported in the literature by H. Werner and co-workers.61  
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2.3.12 Synthesis of [RuCl2PPh(OCH3)2(p-cymene)] (15)                  
 
As [RuCl(P(i-Bu3))2(p-cymene)]SbF6 (11), a monosubstituted monomer (figure 2.11) 
was obtained in an attempt to synthesise the disubstituted one. In this case, even an excess 
of phosphine (PhPCl2) was not enough to obtain the disubstituted version. This is probably 
due to the reaction that the phosphine undergoes before coordinating to the metal centre 
which may form side species. The phosphine loses its chlorines when contacting with the 
reaction solvent (methanol). Scheme 2.5 was followed with the respective phosphine ligand 
(PhPCl2). After reflux and evaporation of solvent under reduced pressure the red wine color 
oil obtained was dissolved in chloroform and a layer of pentane added and left in the freezer 
overnight. Pentane was filtered and diethyl ether added to precipitate a red wine color 
powder. It was washed with diethyl ether and water. [RuCl2PPh(OCH3)2(p-cymene)] (15) is an 
air stable, neutral 18-electron compound obtained in 82% yield.  It was characterized by 1H 
NMR and mass spectrometry which are in agreement with the proposed structure.  
   
Ru
P
Cl Cl
OCH3H3CO
 
Figure 2.11 – Molecular structure of [RuCl2PPh(OCH3)2(p-cymene)] (15). 
 
2.4 Catalytic Studies 
 
2.4.1 Redox Neutral Alkylations (N-alkylations) 
 
In this project the N-alkylation of tert-butylamine with phenethyl alcohol was chosen 
as the model for establishing a competent catalyst for the alkylation of amines with alcohols 
(scheme 2.7). It was chosen because it was already attempted in the laboratory and its 
conditions already optimised.  
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Scheme 2.7 – N-alkylation of phenethyl alcohol with tert-butylamine. 
 
The N-alkylations were carried out following the procedure described by J. Williams 
et. al.
24 The substrate:catalyst ratio (phenethyl alcohol:ruthenium) was 20:1 on a molar basis 
for all the reactions with dimers (2.5 mol % dimer, 5 mol % in ruthenium). With monomers, 
some reactions were 20:1 (5 mol % monomer, 5 mol % in ruthenium) and some others were 
40:1 which allowed concluding something about catalyst loading. When dimers were used 
the dimer:phosphine ratio was 1:2 but when monomers were employed no phosphine ligand 
was added to this one-pot reaction. To the pot were also added phenethyl alcohol and tert-
butyl amine (1:1) in toluene and stirred under reflux for 24 hours. The reactions were set 
one by one in round-bottom flasks out in the open air without degassing or inert gas 
protection throughout. Astra Zeneca45 (biopharmaceutical company) selected the phosphine 
ligands to be used because they showed together with [RuCl2(p-cymene)]2 (1) a big catalytic 
potential of the active catalyst in the N-alkylation depicted in scheme 2.8. Conversion rates 
greater than 97% were obtained. Astra Zeneca also did some solvent screening and found 
out that the best ones appear to be Tetralin or Toluene. 
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Scheme 2.8 – Catalytic synthesis of 4-(phenylmethyl)morpholine by N-alkylation. 
 
In the published conditions of the model N-alkylation of this project24 it is reported 
the use of K2CO3 as a base, inert atmosphere, and anhydrous conditions (dry toluene and 
molecular sieves). But a former colleague from the McGowan’s group (Alan Myden) found 
out that there is no need of such precautions. Following that he managed to obtain the 
product in 79% conversion. 
The optimised conditions in the McGowan’s group were followed. The reaction was 
attempted again to check if same results are obtained and to try to isolate the product since 
it is not commercially available. After several attempts of trying to isolate the product when 
using [RuCl2(p-cymene)]2 (1) as pre-catalyst and dppf as the phosphine ligand, none of them 
were successful. Column chromatography was performed but it did not work using either 
diethyl ether or a mixture of ethyl acetate-hexane as the eluent. A mixture of the starting 
material, the product and several other impurities was always the result. The product, (2-
phenylethyl)tert-butylamine, was isolated together with phenethyl alcohol by reduced 
pressure distillation which allowed the assignment of the retention time of the product in 
gas chromatography since the product is not commercially available.  
After the preliminary studies mentioned above, the project moved into testing all the 
dimer-ligand pairs as well as the monomers as N-alkylation catalysts. Reaction conversions 
were calculated by 1H NMR. 
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2.4.1.1 1H NMR Results 
  
Since it was not possible to isolate the product, conversions were calculated instead 
of yields. The spectrum of one of the catalytic reactions can be seen in figure 2.12 in which 
are shown the peaks which integrals were used to calculate the product conversion. As 
reported by J. Williams and co-workers1 the N-alkylation of tert-butylamine with phenethyl 
alcohol using ruthenium dimer-phosphine pairs is often accompanied by the formation of 
appreciable quantities of PhCH2CH2O2CCH2Ph so, where present, the conversions accounted 
this fact. If both the alcohol and ester peaks are present, the product conversion is 
calculated by manually integrating the alcohol peak against the product and ester peaks. If 
only the ester peak is present, the product conversion is calculated integrating the ester 
peak against the product peak. This ester is formed presumably from addition of alcohol to 
the intermediate aldehyde and oxidation of the so-formed hemi-acetal. This fact was seen 
with the dimer-ligand catalytic systems but also with the ruthenium monomers.  
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
26.972.002.63
(a) (b)
(c)
NH (c)
(c)
(c)
OH
(b)
O
O
(a)
 
Figure 2.12 – 1H NMR spectrum of the oily residue obtained after filtration of the reaction mixture 
through celite of the N-alkylation of tert-butylamine with phenethyl alcohol by [RuCl(dppf)(p-
cymene)]Cl (7). Substrate:catalyst ratio of  40:1. (a), (b) and (c) are the peaks which integrals were 
used to calculate the product conversion. 
 
The results from the N-alkylation reactions of tert-butylamine with phenethyl alcohol 
are shown in table 2.3. 
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Table 2.3 – Results for the N-alkylation of tert-butylamine with phenethyl alcohol. Catalyst/ligand 
evaluation. 
Entry Complex Ligand S/C 
[a] 
Amine (%) 
[b] 
Ester (%) Unreacted 
alcohol (%) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
[RuCl2(p-cymene)]2 (1) 
1 
1 
1 
1 
[RuI2(p-cymene)]2 (2) 
2 
2 
2 
[RuCl(dppf)(p-cymene)]SbF6 (4) 
[RuCl(dppf)(p-cymene)]BF4 (6) 
[RuCl(dppf)(p-cymene)]BF4 (6) 
[RuCl(dppf)(p-cymene)]Cl (7) 
[RuCl(dppf)(p-cymene)]Cl (7) 
[RuI(dppf)(p-cymene)]SbF6 (5) 
[Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) 
[RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) 
[RuCl(P(i-Bu)3)2(p-cymene)]SbF6 (11) 
[RuCl2(P(n-Bu)3)2(p-cymene)] (13) 
[RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) 
– 
dppf 
DPEPhos 
dippf 
P(i-Bu)3 
– 
dppf 
DPEPhos 
dippf 
– 
– 
– 
– 
– 
– 
– 
– 
– 
– 
– 
20 
20 
20 
20 
20 
 
20 
20 
20 
40 
40 
20 
40 
20 
40 
40 
40 
40 
40 
40 
2[c](0) 
75 (100) 
60 
79 (80) 
28 
3[c] 
75 
96 
72 
36 
61 
36 
45 
82 
85 
28 
 0 
9 
0 
0 
(8) 
7 (0) 
37 
21 (20) 
0 
- 
25 
3 
27 
0 
19 
50 
40 
12 
15 
60 
 1 
0 
0 
0 
 92[c](92) 
18 (0) 
4 
0 (0) 
72 
84[c] 
0 
1 
1 
64 
20 
14 
15 
6 
0 
12 
99 
91 
100 
100 
[a] S/C = substrate/catalyst ratio 
[b] Values given are conversions with respect to unreacted alcohol or unreacted ester when no unreacted 
alcohol is present, as determined by analysis of the 1H NMR spectra. Figures in parentheses are conversions 
obtained for the same reaction reported in the literature employing additional 10 mol% K2CO3, 3 Å molecular 
sieves and inert atmosphere. 
[c] This conversion was calculated by GC by the area normalization procedure (comparing peak areas) 
 
As it is possible to be seen, just employing the dimers in the absence of any 
additional ligand afforded negligible consumption of the starting material, which means that 
the dimers it selves do not form any active species towards the N-alkylation under study. On 
the other hand, all the dimer-ligand pairs (1-dppf, 2-dppf, 1-DPEPhos...) and all the 
monomers containing bidentate ligands form catalytically active species. This fact supports 
the idea of having a monomer that will be the actual pre-catalyst. Another idea that is 
supported by the results obtained is that by starting the reaction with [RuCl(dppf)(p-
cymene)]Cl (7) (entry 14) instead of the corresponding dimer-ligand pair (entry 2), the results 
are better (increase of product conversion and reduction in the percentage of unreacted 
alcohol) since a mechanistic step is thought to have been eliminated. By looking at the 
results is also possible to see that the presence of iodine in the complexes instead of 
chlorine led in the majority of the reactions to an improvement of the catalytic performance 
in terms of product conversion and/or reduction in the percentage of unreacted alcohol. For 
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example, from entry 3 ([RuCl2(p-cymene)]2(1)-DPEPhos) to the corresponding iodine entry 
(8) it is possible to see an increase of 36% in terms of amine conversion. Entry 3 is indeed the 
best result obtained for the N-alkylation under investigation with 96% conversion. Also, 
[RuI(dppf)(p-cymene)]SbF6 (5) showed a very high conversion (85%) when compared to the 
respective chlorine analogue [RuCl(dppf)(p-cymene)]SbF6 (4) (entry 10, 36%) in spite of 
having produced the ester derivative (15%) which was not formed in entry 10. This 
improvement of performance when iodine is present in the pre-catalysts instead of the 
chlorine atom is thought to be related to the higher lability of the iodine because by being 
more labile, iodine is easier displaced from the complex to give the actual active 
intermediate which needs to have a vacant site in order to carry on the N-alkylation.  
When comparing the different phosphine ligands it is possible to see that the results 
obtained for dppf and dippf are quite similar. The similarities in their structures seem to be 
the more plausible explanation. A comparison can also be made with the monomers 
containing different counter-ions, [RuI(dppf)(p-cymene)]SbF6 (4), [RuCl(dppf)(p-cymene)]BF4 
(6) and [RuCl(dppf)(p-cymene)]Cl (7). It can be seen that the amount of unreacted alcohol 
decreases from 4 to 7 (entry 10, 11 and 13). But the yield does not increase in the same 
pattern. This fact goes against the idea that ruthenium complexes with larger, less 
coordinating anions should be more effective in catalysis. 
Another curious fact found herein is that [RuCl2(p-cymene)]2(1) showed a very poor 
catalytic performance in the presence of the monodentate ligand P(i-Bu3) (entry 5) with 72% 
of unreacted alcohol and 28% of product. This result is against the one expected since P(i-
Bu3) was recommended by Astra Zeneca
45 as a very good phosphine ligand for this type of 
reactions. The first thought was that since the reactions have been ran out in the open air 
without degassing or inert gas protection throughout, the phosphines might have been 
oxidised into phosphine oxides. So the same reaction was ran under an inert dry nitrogen 
atmosphere, with all the glassware being properly dried, dry toluene and degassed reagents. 
Molecular sieves were employed in the reaction. Even with these conditions, the reaction 
output was even worse than before, with 96% of unreacted alcohol and 0% of product. This 
result found with [RuCl2(p-cymene)]2(1) and P(i-Bu3) was corroborated with the poor 
catalytic results shown by the respective disubstituted monomer [RuCl(P(i-Bu)3)2(p-
cymene)]SbF6 (11) (entry 18, 9% product conversion). The other disubstituted monomers 
([RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) and [RuCl(P(CH3)3)2(p-cymene)]SbF6 (14)) do not form 
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any active catalytic species (0% product, ≈100% alcohol). With these results some 
speculation could arise weather it is necessary the monomer to be mono or disubstituted 
with phosphine but results obtained with the mono substituted monomer [RuCl2P(n-Bu3)(p-
cymene)] (13) shows that no catalytic species is formed as well (0% product, 100% alcohol).  
In terms of substrate/catalyst (S/C) ratios the results are somewhat contradictory.  
When S/C ratio was 40 with [RuCl(dppf)(p-cymene)]Cl (7) the product conversion was 45%; 
when the amount of ruthenium was doubled (20 of S/C ratio) the product conversion has 
doubled as well (82%). But for [RuCl(dppf)(p-cymene)]BF4 (6) the opposite situation occurred 
(entries 11 and 12). The only factor common to both compounds is that when S/C ratio is 
increased the amount of unreacted alcohol diminishes. About [Ru2(NCCH3)2(DPEPhos)2]SbF6 
(8), it shows low amount of unreacted alcohol (12%) but the biggest amount of ester within 
all the entries (68%), and consequently one of the lowest product conversions (28%). Is 
though, an interesting result, since it forms catalytically active species.  
As it was possible to see throughout the results mentioned before, almost every 
reaction produced the ester PhCH2CH2O2CCH2Ph as a side product. However, there was not a 
pattern that could be assigned. For example, [RuI(dppf)(p-cymene)]SbF6 (4) (entry 10) gave 
no ester but [RuCl(dppf)(p-cymene)]BF4 (6) that just differs in the counter-ion gave 19% 
(entry 11). This randomness formation of ester may be related with mechanistic issues or 
reaction kinetics. The mechanism of N-alkylation of secondary amines with primary alcohols 
proposed by J. Williams and co-workers1 is shown in scheme 2.9. 
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In the borrowing hydrogen mechanism proposed it is believed that p-cymene is 
dissociated in the active complex since J. Williams and co-workers1 showed that the reaction 
of [RuCl2(p-cymene)]2 (1) with BINAP and the diamine DPEN leads to the formation of the 
Noyori complex Ru(BINAP)(DPEN)Cl2. In other words, they showed the displacement of p-
cymene. They also observed p-cymene in the crude 1H NMR spectra at the end of N-
alkylation reactions they performed. Because of this, they believe that complex 20 is 
generated where Ln represents the bidentate phosphine and probably amine ligands. To 
have some more insight about incorporation of both amines and phosphines into the same 
monomer, the reaction between [RuCl(dppf)(p-cymene)]SbF6 (4) and a big excess of pyridine 
(16 molar equivalents) in the presence of an equivalent of NaSbF6 was attempted, at room 
temperature (see scheme 2.11). The starting monomer was obtained in the end. Also, the 
pyridine monomer [RuCl2(p-cymene)(NC5H5)] was reacted by a person in the group (A. 
Rodríguez) with one molar equivalent of dppf in the presence of 10 molar equivalents of 
NaSbF6 which afforded [RuCl(dppf)(p-cymene)]SbF6 (4). These two reactions show the bigger 
lability of chlorine atoms and pyridine compared to dppf and p-cymene since the last ones 
Scheme 2.9  – Proposed mechanism by J. 
Williams and co-workers1 of N-Alkylation 
Reactions Involving Enantiomerically 
Pure Substrates. 
Scheme 2.10 – Hydrogen/Deuterium 
crossover study in Morpholine Alkylation 
by J. Williams and co-workers.1 
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remained complexed in the first reaction and pyridine and chlorine did not in the second 
one. These facts do not support the first mechanistic step proposed by J. Williams and co-
workers.  
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Scheme 2.9 – Reaction between [RuCl(dppf)(p-cymene)]SbF6 (4) and pyridine (top left) and between 
[RuCl2(p-cymene)(NC5H5)] and dppf (bottom left).   
 
The second mechanistic step in their sequence consists in the activation of complex 
20 by exchange of a chloride with alcohol, and loss of HCl. The alkoxy complex then formed 
undergoes a β-hydride transfer giving LnRuHCl(O=CHR) which leads to complex 21 by loss of 
aldehyde and HCl. Oxidative addition of the alcohol provides the alkoxy hydride complex 22, 
which can then undergo β-hydride transfer to form the aldehyde complex 23. It was proven 
by the authors that this complex can dissociate from the ruthenium and that imine 
formation does not necessarily take place while coordinated. They performed a crossover 
experiment (scheme 2.10) were the deuterated alcohol 16 and the 13C labeled alcohol 17 
were reacted in the same pot with morpholine to provide the N-benzylated morpholine 
adducts 18 and 19. They observed deuterium incorporation in both the unlabeled product 
18 and the labelled product 19. Was therefore a crossover of the deuterium to the 13C 
labelled benzyl group. By other words, there was the displacement of aldehyde from a non-
deuterated complex (23) and later, the imine that resulted from this aldehyde, complexed to 
a deuterated ruthenium dihydride (24) which transferred its protons to it. Also, the higher 
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deuterium incorporation found in compound 53 is consistent with the fact that only one of 
the C-D bonds needs to be broken in order for the reaction to take place. The dissociation of 
the aldehyde, imine formation and recomplexation leads to the imine complex 25, 
presumably by the dihydride complex 24. Complex 25 then undergoes β-hydride transfer to 
give the amido complex 26 which suffers reductive elimination to afford the amine product 
and the regeneration of the ruthenium(0) complex 21. 
 The dissociation process found for the intermediate aldehyde may explain some of 
the results obtained in the N-alkylations of this project, namely the ester conversions. For 
example, the N-alkylations where no ester formation was seen may be explained in terms of 
not occurring the dissociation of the intermediate aldehyde. This should prevent the 
aldehyde from reacting with unreacted alcohol and forming the ester. The different values of 
ester conversions from compound to compound may also be explained in part in terms of 
preferred routes of the catalytic intermediates. Some catalytic intermediates may undergo 
N-alkylation mainly by dissociation of the aldehyde intermediate giving a considerable 
amount of ester while others may prefer the non-dissociation mechanistic step. Reaction 
kinetics is also thought to be responsible for the differences found for ester conversions. 
 
 
2.4.1.2      Gas Chromatography Analysis 
 
The model N-alkylation of this project was monitored by gas chromatography. Just 
the pre-catalyst pair [RuCl2(p-cymene)]2(1)-dppf was followed by this technique. The 
procedure is based on previous work done in a similar field by the Process Lab of the School 
of Chemistry of the University of Leeds under the supervision of Dr. John Blacker. It 
consisted of taking 20 µL samples from the reaction mixture from time to time during 24 
hours, diluting them with acetonitrile and adding decane as a standard. Conversions were 
calculated using the internal standard method. 
The results from the N-alkylation catalysed by [RuCl2(p-cymene)]2(1) and dppf during 
24 hours are shown in table 2.4 and during the first 5 hours plotted in figure 2.13.  
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Table 2.4 – Alcohol and product concentrations over time in the N-alkylation catalysed by [RuCl2(p-
cymene)]2 (1) in the presence of dppf. 
Time/ hours 
Concentration 
Alcohol/ M 
Concentration 
Product/ M 
Conversion 
/ % 
0 1.82E-01 0.00E+00 0.0 
0.25 1.92E-01 1.92E-03 1.1 
0.5 1.58E-01 2.29E-03 1.3 
0.75 1.70E-01 2.10E-03 1.2 
1 1.68E-01 4.74E-03 2.6 
1.25 1.60E-01 6.04E-03 3.3 
1.5 1.65E-01 8.36E-03 4.6 
1.75 1.61E-01 1.00E-02 5.5 
2 1.64E-01 1.25E-02 6.9 
2.5 1.48E-01 1.45E-02 8.0 
3 1.51E-01 1.83E-02 10.1 
4 1.44E-01 2.31E-02 12.7 
5 1.27E-01 2.51E-02 13.8 
23 7.49E-02 4.02E-02 22.1 
24 6.57E-02 3.65E-02 20.1 
 
 
Figure 2.13 – Variation of the product and alcohol concentration in an N-alkylation catalysed by 
[RuCl2(p-cymene)]2 (1) in the presence of dppf ligand. 
 
 As it is possible to see from table 2.4, conversions were all very low in comparison to 
what was expected. From the 1H NMR for the same reaction (not for the same experiment), 
the final conversion (after 24h) was 75% for the amine product. Although the results 
obtained by 1H NMR come from a different experiment, both reactions were run under the 
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same conditions and the high conversion found by 1H NMR agrees with the literature1. The 
same reaction was ran again and followed by GC but more or less the same conversions 
were obtained. Conversions were recalculated using the area normalization procedure 
(comparing peak areas) instead of the internal standard method but low conversions were 
also obtained.  This reaction was found to be very sensitive to changes in solvent volume, 
fact that was taken into account while running the reactions.  
Another curious observation from table 2.4 is that the initial alcohol concentration 
(1.82E-01 M) does not match to the expected value (3E-01 M). Though, it is possible to see 
from figure 2.13 that the rate of decrease of the alcohol concentration (0.0099 mol dm-3 h-1) 
is higher than the rate of formation of the product (0.0054 mol dm-3 h-1) which is consistent 
with the observation made before in the 1H NMR analysis that the reaction is forming a side 
product, namely PhCH2CH2O2CCH2Ph.  
 After 23 hours of reflux, the product concentration was 4.02×10-2 M and after 24 
hours it was 3.65×10-2 M. This fact means that the reaction had already proceeded to 
completion.  
Due to the incoherence of the conversions, due to the inoperability of the gas 
chromatographer for a long period of time and some issues concerning the method of 
analysis, the reactions followed by gas chromatography were abandoned. 
 
2.4.2 Transfer hydrogenations 
 
In this project two transfer hydrogenations were studied, namely the reduction of 
acetophenone and the reduction of benzaldehyde. Both were carried out using the same 
general procedure. The substrate:catalyst ratio (acetophenone or benzaldehyde:ruthenium) 
was 100:1 on a molar basis (0.5 % mol dimer or 1 % mol monomer). As in N-alkylations, 
when dimers were used the dimer:phosphine ratio was 1:2 but when monomers were 
employed no phosphine ligand was added to the reaction. The reactions were set in a 
Radley’s carousel (figure 2.14), which was set upon a stirrer hot plate. This type of apparatus 
ensures that several reactions are run under the same conditions which give faster and more 
comparable results. The reactions were set under normal atmosphere. 
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Figure 2.14 – Schematic for the Radley’s carousel used for batch reactions. Adapted from J. Williams 
and co-workers.27 
 
2.4.2.1 Reduction of Acetophenone 
 
The usual transfer hydrogenation that is tried within McGowan’s group is the one 
involving acetophenone reduction with isopropanol and potassium tert-butoxide (figure 
2.15). This reaction yields a racemic mixture since the ligands employed are not chiral. But 
the project is not concerned about obtaining enantiopure compounds, but more interested 
about catalytic activity. So the reaction output, this is the conversion (which includes both 
isomers), was calculated by 1H NMR like in the N-alkylations. In figure 2.15 can be seen the 
product and starting material peaks used to figure out the conversions. The reactions were 
catalysed by the dimer-ligand catalytic systems and by the monomers that have been 
synthesised. 
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Figure 2.15 – 1H NMR spectrum of the oily residue obtained after evaporation of the reaction mixture 
of the conversion of acetophenone to 1-phenylethanol by transfer hydrogenation using [RuCl2(p-
cymene]2(1)-dppf as pre-catalyst. The reaction scheme is also depicted. (a) and (b) are the peaks 
which integrals were used to calculate the product conversion. 
 
The results from the reduction of acetophenone by transfer hydrogenation are 
shown in table 2.5. This table also contains results of the same transfer hydrogenations using 
different catalysts that can be found in the literature and may be useful to make some 
comparisons.  
 
Table 2.5 – Results for the reduction of acetophenone to 1-phenylethanol by transfer hydrogenation. 
The base employed is t-BuOK and the hydrogen source is isopropanol unless otherwise stated. 
Complex Ligand Temp. 
(˚C) 
h S/C Conv. 
(%) 
[RuCl2(p-cymene)]2 (1) 
1 
1 
1 
[RuI2(p-cymene)]2 (2) 
2 
2 
2 
[RuCl(dppf)(p-cymene)]Cl (7) 
 [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6(8) 
[RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) 
– 
dppf 
DPEPhos 
dippf 
– 
dppf 
DPEPhos 
dippf 
– 
– 
– 
 
 
 
 
 
60 
 
 
 
 
 
 
 
20 
 
 
 
 
 
 
100 
67 
25 
21 
43 
19 
22 
7 
54 
8 
40 
3 
1 
1 
[RuCl2(η
6-mesitylene)]2 
[RuCl(S,S)-TsDPEN(η6-mesitylene)] 
A 
B 
(S,S)- TsDPEN 
– 
40 
40 
r.t. 
28 
20 
20 
15 
20 
200 
200 
200 
200 
10[a] 
5[a] 
95[b] 
99[c] 
[a] Ligand A and B are depicted in figure 2.16.  Ketone:base:[RuCl2(p-cymene)]2:ligand = 200:20:1:2.
62  
[b] The value in percentage is actually the yield of the reaction. Ketone:Ru:(S,S)-TsDPEN:KOH = 200:1:2:5.50  
[c] The value in percentage is actually the yield of the reaction. It was carried out in a formic acid-triethylamine 
mixture (5:2, 2.5 mL).20 
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Figure 2.16 – BINOL-derived diphosphonites which have proven to be excellent ligands for 
asymmetric olefin hydrogenation and other reactions.62 A = 1,1'-Bis[(11bR)-dinaphtho[2,1-d:1', 2'-
f][1,3,2]dioxaphosphepin-4-yl]ferrocene; B = (11bR, 11'bR)-4,4'-(Oxydi-2,1-phenylene)bis-
dinaphtho[2,1-d:, 1', 2'-f][1,3,2]dioxaphosphepin.  
 
It can be seen that the conversion pattern in the reduction of acetophenone is 
basically opposite to the one shown by the same pre-catalysts in N-alkylations and that none 
of the pre-catalysts showed the high efficiency of the [RuCl2(η
6-mesitylene)]2– (S,S)- TsDPEN 
dimer-ligand pair or the renowned complex [RuCl(S,S)-TsDPEN(η6-mesitylene)], both 
disclosed by Noyori and co-workers20, 50. In here, [RuCl2(p-cymene)]2 (1) in the absence of 
any additional ligand afforded the best product conversion while in the corresponding N-
alkylation it afforded minimal consumption of starting material. Also, the presence of 
phosphine ligands together with [RuCl2(p-cymene)]2 (1) did not improve or did not improve 
much the percentage of starting material converted, whereas in N-alkylation it was crucial. 
This may be explained in terms of mechanistic features as it is going to be discussed later. A 
result found in the literature62 with [RuCl2(p-cymene)]2 (1) in the presence of a dppf related 
ligand (A) gave a poor conversion into the product as well, proving the inefficacy of these 
ligands. Another fact is that [RuI2(p-cymene)]2 (2) did not improve the conversion when 
compared to [RuCl2(p-cymene)]2 (1) (except in the case of the [RuI2(p-cymene)]2 (2)-dippf 
pair). Something can also be said about the pair [RuI2(p-cymene)]2 (2)-DPEPhos which in the 
N-alkylation was the best pre-catalyst. This time, it was one of the worst (7% conversion). 
The same can be said about [RuCl(dppf)(p-cymene)]Cl (7). Poor results were also found in 
the literature62 with a DPEPhos related ligand (B) proving the inefficacy of these ligands. 
[RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) showed again that is not suitable for the catalytic 
reactions under study (only 3% conversion). [Ru2(NCCH3)2(DPEPhos)2]SbF6 (8) although not 
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being the best pre-catalyst, it showed it forms catalytically active species in both transfer 
hydrogenations and N-alkylations. Just to have more insight about trichloro-bridged 
complexes, in the literature it is possible to find that the structure related compound 
[Ru2Cl3(dppb)2(MeCN)2]PF6 (dppb = diphenylphosphino butane)  forms catalytically active 
species in the reduction of CH2N=C(R)Ph (R=H or Me) with H2.
63
 
In a typical hydrogenation reaction, the basic requirements are the formation of 
metal hydride species and a free coordination site for maintaining the catalytic cycle.2 In the 
present case, there is the generation of different hydrides according to the pre-catalyst 
employed. For the dimers it selves it is supposed to occur the generation of a metal 
dihydride according to what was proven for the complex RuCl2(PPh3)3 (RuH2(PPh3)3 being the 
active catalyst)17 which is similar to each half of the ruthenium dimer, RuX2(p-cymene) (X=Cl 
or I). A proposed mechanism for the reduction of acetophenone and benzaldehyde catalysed 
by ruthenium dimers is shown in scheme 2.12.  
 
[RuX2(p-cymene)]2 OH ORuX(p-cymene)+
OH
t-BuOK
-HCl
ORuH(p-cymene)
t-BuOK
-HCl -acetone
RuHX(p-cymene)
-elimination
Ru
Ph
O
R
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Ru
OH
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R
OH
Ru
OH
O
Ph R
OH
-acetone
-elimination
27 28
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32
 
Scheme 2.10 – Proposed catalytic cycle in the present study for the reduction of acetophenone 
(R=CH3) and benzaldehyde (R=H) employing ruthenium dimers in the absence of any additional 
ligands. X = halide. 
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The reaction of the ruthenium dimer with isopropanol in the presence of a base facilitates 
the formation of a ruthenium alkoxide (27) by abstracting the proton of the alcohol. The 
alkoxide then undergoes a β-elimination to give the chloride/iodide-monohydride complex 
28. In order to turn the complex catalytically active it needs to go through the base-
promoted sequence of alkoxyde formation-β-elimination a second time to replace also the 
second halide by hydride. This gives the dihydride complex 30 which is thought to be the 
active catalyst. Then occurs the addition of the acetophenone/benzaldehyde into the 
coordination sphere of the metal followed by a migratory insertion into the Ru-H bond to 
give the alkoxy complex 31. This complex then undergoes a reductive elimination followed 
by an oxidative addition of isopropanol releasing the corresponding product. The complex 
then formed, 32, suffers a reductive elimination releasing acetone. 
As seen, the dimers in the absence of any additional ligands are supposed to follow 
the dihydride mechanism. The same route was not found by Backväll and co-workers for the 
complex [RuCl(dppp)(p-cymene)]Cl2 (dppp = 1,3-Bis(diphenylphosphino)propane). By 
deuteration experiments they found out that this complex undergoes transfer 
hydrogenation mainly by a monohydride mechanism. This result suggests that the 
monomers synthesised in this project, few of them quite similar in structure to 
[RuCl(dppp)(p-cymene)]Cl, should follow the same route. By association, the dimer-ligand 
pairs herein studied should follow the monohydride path as well. A proposed mechanism for 
this path is shown in scheme 2.13. 
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Scheme 2.11 – Proposed catalytic cycle in the present study for the reduction of acetophenone 
(R=CH3) and benzaldehyde (R=H) employing ruthenium dimers in the presence of biphosphine ligands 
or just employing diphosphine ruthenium monomers (33). X = halide. 
 
 
The complexation of a bidentate phosphine to the ruthenium dimer should lead to 
the formation of the cationic 18 electron complex [Ru(P-P)(p-cymene)Cl]+ (33). In order to 
turn it catalytically active it needs to go through the base-promoted sequence of alkoxyde 
formation-β-elimination to give the hydride complex 35. Then occurs the addition of the 
acetophenone/benzaldehyde into the coordination sphere of the metal followed by a 
migratory insertion into the Ru-H bond to give the alkoxy complex 36.  In order to maintain 
the catalytic cycle this complex needs to generate a free coordination site. The idea is that 
the phosphine ligand behaves as hemilabile, alternating between bidentate to monodentate 
coordination thereby allowing coordination of isopropanol to take place and then the 
releasing of the product. This path should not be in principle very favourable due to the 
strong binding of chelate complexes. This fact might explain the poor results obtained for 
the dimers in the presence of the diphosphine ligands and for the monomers.  
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2.4.2.2 Reduction of Benzaldehyde 
 
The other transfer hydrogenation that was studied in this project was the reduction 
of benzyldehyde with isopropanol and potassium tert-butoxide in the presence of the same 
pre-catalysts mentioned before. For this reaction the product does not consist in a racemic 
mixture. Conversions were calculated as before. In figure 2.17 it can be seen the product and 
starting material peaks used to figure out the conversions. 
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Figure 2.17 – 1H NMR spectrum of the oily residue obtained after evaporation of the reaction mixture 
of the conversion of benzaldehyde to benzyl alcohol by transfer hydrogenation using [RuCl2(p-
cymene]2 (1)-DPEPhos as pre-catalyst. The reaction scheme is also depicted. (a) and (b) are the peaks 
which integrals were used to calculate the product conversion. 
 
The results from the reduction of benzaldehyde by transfer hydrogenation are shown 
in table 2.6 and a comparison of the catalytic activities according to the substrate 
(acetophenone or benzaldehyde) is depicted in figure 2.18.  
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Table 2.6 – Results for the reduction of benzaldehyde to benzyl alcohol by transfer hydrogenation. 
The base employed is t-BuOK and the hydrogen source is isopropanol. 
Complex Ligand Substrate Temp. 
(˚C) 
h S/C Conv. 
(%) 
[RuCl2(p-cymene)]2 (1) 
1 
1 
1 
[RuCl2(p-cymene)]2 (1) 
2 
2 
[RuCl(dppf)(p-cymene)]Cl (7) 
[RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) 
– 
dppf 
DPEPhos 
dippf 
– 
dppf 
DPEPhos 
– 
– 
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From table 2.6 it can be seen that the conversion pattern is basically the same shown 
by the same pre-catalysts in the reduction of acetophenone. Again, [RuCl2(p-cymene)]2 (1) in 
the absence of any additional ligand afforded the best product conversion and the presence 
of phosphine ligands did not improve the percentage of starting material converted. Another 
similar fact is that [RuI2(p-cymene)]2 (2) did not improve the conversion when comparing to 
[RuCl2(p-cymene)]2 (1). For this reaction, although showing again the poorest performances, 
the [RuI2(p-cymene)]2 (2)-DPEPhos pair and [RuCl(dppf)(p-cymene)]Cl (7) gave substantially 
better conversions compared to those in the reduction of acetophenone (34 and 47% dimer-
ligand pair and monomer respectively, against 7 and 8%). In fact, all the pre-catalysts tested 
in the reduction of benzaldehyde showed a better performance (substancial increase in 
conversion) in comparison with their performance in the reduction of acetophenone (figure 
2.18). This is thought to be related to the CH3 group in the acetophenone that provides steric 
hindrance for the insertion of this ketone into the coordination sphere of the metal. 
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Figure 2.18 – Comparison of the catalytic activities according to the substrate in the reduction of 
acetophenone and benzaldehyde by transfer hydrogenation. 
 
3. Conclusions 
 
A range of in situ generated catalysts (p-cymene ruthenium dimers in the presence of 
phosphines) and p-cymene based ruthenium monomers have been employed in the N-
alkylation of t-butylamine with phenethyl alcohol and reduction of acetophenone and 
benzaldehyde by transfer hydrogenation. 
Some p-cymene based ruthenium half-sandwich complexes (monomers) have been 
successfully prepared with various phosphine ligands (dppf, P(n-Bu)3, P(i-Bu)3, P(CH3)3, 
PhPCl2), some of them forming catalytically active species towards the reactions of interest.  
It has been demonstrated that p-cymene based ruthenium complexes can provide 
highly active and selective catalysts in the alkylation of t-butylamine with phenethyl alcohol 
either by the use of dimers in the presence of phosphines or by the use of phosphine 
containing monomers. Namely [RuI2(p-cymene) with DPEPhos (substrate/catalyst ratio of 20) 
gave 96% conversion into the amine product and [RuI(dppf)(p-cymene)]SbF6 (5) gave 85% 
with a substrate/catalyst ratio of 40 being the only precursor with this S/C ratio giving 0% of 
unreacted alcohol, which is a very promising result. Also, these reactions have been run out 
in the open air without degassing or inert gas protection throughout which is not the typical 
approach found in the literature and which can be very appealing in the industrial point of 
view.  
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More conclusions about N-alkylations are drawn as follows: 
– Results suggest that [RuX(LL)(p-cymene)]+ complexes where X=halide and 
LL=bidentate ligand are the catalytic precursors in reactions employing [RuX2(p-cymene)]2 
and bidentate phosphines; 
– The presence of iodine in the ruthenium complexes instead of chlorine usually led 
to an increase in the catalytic activity of the active catalyst species formed; 
– When comparing the effect of the counter-ion, namely between [RuCl(dppf)(p-
cymene)]SbF6 (4), [RuCl(dppf)(p-cymene)]BF4 (6) and [RuCl(dppf)(p-cymene)]Cl (7), 7 seems 
to be the best catalyst precursor (82% conversion into amine), which is expected to be the 
species formed in the reaction; 
– Monodentate phosphines seem to be not suitable for these reactions since their 
incorporation in the catalyst precursors led to inactive or very poor catalytic species; 
– The formation of ester as side product seen in these reactions may be explained in 
terms of the dissociation process found in the mechanism for the intermediate aldehyde 
complex. 
 
In the transfer hydrogenation reactions concerning the reduction of acetophenone 
and benzaldehyde, it has been demonstrated that the catalyst precursors employed are not 
the most suitable for this these reactions. Overall, conversions up to 73% were obtained 
which lag far behind the 100% reported in the literature for several other catalysts, the most 
representative ones disclosed by Noyori. 
Although the conversions obtained for the reduction reactions are not very appealing 
for further use of the catalyst precursors, the results allowed to draw some interesting 
conclusions: 
– The dimers in absence of any additional ligand afforded the best product 
conversion and the presence of phosphine ligands and iodine in the catalyst precursors did 
not improve or did not improve much the percentage of starting material converted. These 
facts are somewhat opposite to the trends in N-alkylations; 
– Again, monodentate phosphines seem not to be suitable for hydrogen transfer 
reactions, with complex [RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) forming a very poor catalytic 
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species (3% and 12% conversion for the reduction of acetophenone and benzaldehyde, 
respectively); 
– The results suggest that the dimers in the absence of any additional ligands follow a 
catalytic mechanism other than the one followed by dimers in the presence of phosphines or 
by ruthenium monomers and a catalytic cycle for both cases has been proposed. 
– All the pre-catalysts tested in the reduction of benzaldehyde showed a better 
performance (substancial increase in conversion) in comparison with their performance in 
the reduction of acetophenone.  
 
Unexpected complex [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6(8) has been synthesised and 
has shown it forms catalytically active species in both the alkylation of t-butylamine (28% of 
amine and only 12% of unreacted alcohol) and reduction of acetophenone (40% conversion) 
giving moderate conversions. The use of trichloro-bridged complexes in such reactions has 
not been demonstrated before as far as it is known which opens new fields of application for 
these complexes.  
    
 
4. Future Work 
 
As it was possible to be seen, the most promising results were achieved in N-
alkylations. Because of this and since these reactions have been much less documented than 
transfer hydrogenations of unsaturated compounds and are increasing their importance to 
the pharmaceutical industry, future work would focus on this type of reaction. 
An important work for those who later want to carry on this investigation is the 
monitoring of the best pre-catalysts ([RuI2(p-cymene)]2-DPEPhos, [RuI(dppf)(p-cymene)]SbF6 
(5) and [RuCl(dppf)(p-cymene)]Cl (7)) in N-alkylations by GC. This will allow gaining more 
insight about reaction kinetics and a comparison of pre-catalysts in terms of 
fastness/velocity constants can be made. This will also allow the determination of when the 
N-alkylations are finished leading to an improvement of the method.  
Studies that can be of a great importance are those investigating the effects of 
changing the reaction conditions in the N-alkylations using the best pre-catalysts found. 
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Namely, studies employing lower boiling point solvents which would permit the application 
of N-alkylations to sensitive substrates.  
The next step in this project would have been the immobilization of the pre-catalysts 
for heterogeneous catalysis. Homogeneous catalysts usually offer the best results in activity 
and selectivity, however they have a major drawback in recyclability processes, because they 
are not easily separated and recovered from a reaction mixture. This clearly limits their 
industrial applications. To overcome this, immobilization of the best pre-catalysts found in 
this project would have been attempted.  
 The synthesis and application of more p-cymene based ruthenium monomers 
incorporating bidentate phosphines and iodine seems to the path to follow in N-alkylations. 
   
5. Experimental Procedures 
 
5.1 General Experimental Considerations 
 
Unless otherwise stated, all manipulations involving the synthesis of the compounds 
mentioned were under normal atmosphere, with no need of using standard Schlenk line 
techniques. 
Chemicals were obtained from Sigma-Aldrich Chemicals Co. (this includes deuterated 
NMR solvents), Alfa Aesar, Fisher Scientific, SAFC Supply Solutions, Fluka Analytical, Acros 
Organics, VWR International Ltd. and the Department of Chemistry breached bottle store, 
and they were used without further purification. 
The NMR spectra were acquired by the author using a Bruker DPX 300 MHz 
spectrometer, a Bruker DRX 500 MHz spectrometer or by Mr. Simon Barrett using a Bruker 
DRX 500 MHz spectrometer. Microanalyses were obtained by Mr. Ian Blakely at the 
University of Leeds Microanalytical Service. Mass Spectra were obtained by Ms. Tanya 
Marinko-Covell at the University of Leeds Mass Spectrometry Service. X-ray diffraction data 
were collected and solved by Mr. Colin Kilner and Mr. David Crabtree, on a Nonius 
KappaCCD area detector diffractometer using graphite monochromated Mo-Kα radiation (λ 
= 0.71073 Å).  
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All the complexes herein synthesised were properly dried under vacuum and 
anhydrous conditions before submitting them to elemental analysis although some NMR 
spectra show several solvent peaks. 
 
5.2 Synthesis of the complexes 
 
5.2.1 Synthesis of [RuCl2(p-cymene)]2 – C20H28Cl4Ru2 (1) 
 
α-Terpinene (23 mL, 0.13 mol, 90%) was added to a solution of RuCl3.3H2O (5.02 g, 
19.2 mmol) in ethanol (200 mL) and heated under reflux for 24 hours. After reducing the 
volume in vacuo (1:3), the solution was stored in the freezer (-20 ˚C) overnight. A red 
precipitate was filtered off, washed with ice cold diethyl ether and dried in vacuo to yield a 
red crystalline powder. 
Yield: 5.39 g, 8.81 mmol (92%) 
Analysis for C20H28Cl4Ru2 
Found: C 39.35; H 4.60; Cl 23.05 % 
Calculated: C 39.22; H 4.61; Cl 23.16 % 
1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 1.28 [d, 12H, 
3J(1H,1H) = 6.84 Hz,  6H, CH(CH3)2], 2.16 
[s, 6H, C6H4CH3], 2.92 [sept, 2H, CH(CH3)2], 5.34 [d,
 3J(1H,1H) = 5.56 Hz, 4H, η6-C6H4], 5.47 [d,
 
3J(1H,1H) = 5.56 Hz, 4H, η6-C6H4)] ppm; 
ES MS (+): m/z 575.9 [MH+] – Cl. 
 
5.2.2 Synthesis of [RuI2(p-cymene)]2 – C20H28I4Ru2 (2) 
  
A solution of NaI (3.6572 g, 24.4 mmols) in water (32 cm3) was added to a solution of 
[RuCl2(p-cymene)]2(1) (489.6 mg, 0.8 mmols) in CHCl3 (40 cm
3). It was stirred at room 
temperature for three days. The two phases were separated and the organic phase was 
washed with water (1×40 cm3) and brine (1×40 cm3). It was dried over anhydrous Na2SO4 and 
CHCl3 was evaporated. The solid was dissolved in dichloromethane and precipitated with 
hexane to yield a very dark violet crystalline powder. 
Yield: 709.6 mg, 0.725 mmol (91%) 
Analysis for C20H28I4Ru2 
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Found: C 24.90; H 3.50 % 
Calculated: C 24.56; H 2.88 %         
1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 1.25 [d, 12H, 
3J(1H,1H) = 6.84 Hz,  6H, CH(CH3)2], 2.36 
[s, 6H, C6H4CH3], 3.02 [sept, 2H, CH(CH3)2], 5.43 [d,
 3J(1H,1H) = 5.98 Hz, 4H, η6-C6H4], 5.53 [d,
 
3J(1H,1H) = 5.98 Hz, 4H, η6-C6H4)] ppm. 
ES MS (+): m/z 852.7 [MH+] – I. 
 
5.2.3 Synthesis of [RuBr2(p-cymene)]2 – C20H28Br4Ru2 (3) 
 
This experimental procedure did not obtain the product pure neither useful to use in 
further reactions. It just shows the attempt that has worked better to try to obtain this dimer. 
  
 A solution of NaBr (1.2552 g, 12.2 mmols) in water (16 cm3) was added to a solution 
of [RuCl2(p-cymene)]2 (1) (0.1224 g, 0.2 mmols) in CHCl3 (10 cm
3) and heated under reflux for 
1 day. It was left just stirring for more 2 days. The two phases were separated and the 
organic layer was washed with water (2×20 cm3) and brine (1×20 cm3). It was dried over 
anhydrous Na2SO4 and CHCl3 evaporated. The solid was dissolved in dichloromethane and 
precipitated with hexane to yield an orange powder. 
Yield: 83.4 mg, 0.106 mmol (53%) 
Analysis for C20H28Br4Ru2 
Found: C 36.80; H 4.25 % 
Calculated: C 30.40; H 3.57 % 
1H NMR (CDCl3, 500.23 MHz, 300 K): same as compound 1 but broadened. 
 
5.2.4 Synthesis of [RuCl(dppf)(p-cymene)]SbF6 – C44H42P2ClFeRu(SbF6) (4) 
 
5.2.4.1 Method 1 
 
To a suspension of [RuCl2(p-cymene)]2 (1) (200 mg, 0.328 mmol) in a mixture of 
CH3OH/CH3CN (1:1, 20 cm
3) was added NaSbF6 (169.7 mg, 0.656 mmol). The mixture was 
stirred for 30 minutes to yield an orange solution. After this time, dppf (379.8 mg, 0.685 
mmol) dissolved in THF (30 cm3) was added and left stirring for 1h. The solvent was removed 
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in vacuo to give a dark orange solid. It was washed with an ethanol/water (4:1) mixture and 
filtered. The solid was recrystallised from a mixture of ethanol/acetone (4:1) and washed 
with ethanol and water to afford a brownish orange powder. 
Yield: 201.8 mg, 0.190 mmol (29%) 
Analysis for C44H42P2ClFeRu(SbF6) 
Found: C 49.75; H 3.95; Cl 3.30 % 
Calculated: C 49.81; H 3.99; Cl 3.34 % 
1H NMR ((CD3)2CO, 500.23 MHz, 300 K): δ = 0.88 [d, 
3J(1H,1H) = 6.95 Hz,  6H, CH(CH3)2], 1.05 
[s, 3H, C6H4CH3], 2.75 [m, 1H, CH(CH3)2],  4.21 [s, 2H, Cp], 4.40 [s, 2H, Cp], 4.49 [s, 2H, Cp], 
5.06 [s, 2H, Cp], 5.52 [d, 3J(1H,1H) = 5.96 Hz, 2H, η6-C6H4], 6.12 [‘d’, 
3J(1H,1H) = 5.96 Hz, 2H, η6-
C6H4], 7.50 [m, 4H, m-CH of Ph], 7.52 [m, 2H, p-CH of Ph], 7.72 [m, 4H, o-CH of Ph], 7.72 [m, 
4H, m-CH of Ph], 7.78 [m, 2H, p-CH of Ph], 7.87 [m, 4H, o-CH of Ph] ppm.  
1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 0.88 [s (br.), 6H, CH(CH3)2], 0.96 [s, 3H, C6H4CH3], 
2.64 [s (br.), 1H, CH(CH3)2],  4.08 [s, 2H, Cp], 4.28 [s, 2H, Cp], 4.36 [s, 2H, Cp], 5.05 [s, 2H, Cp], 
5.14 [s (br.), 2H, η6-C6H4], 5.67 [s (br.),
 2H, η6-C6H4)], 7.39-7.49, 7.52-7.63, 7.65-7.75 [3m, 
20H, CH of Ph] ppm. 
13C{1H} NMR ((CD3)2CO), 125.76 MHz, 300 K): δ = 14.95 [s, 1C, CH3 of 
CH3C(CH)2(CH)2CCH(CH3)2], 21.00 [s, 2C, CH3 of CH3C(CH)2(CH)2CCH(CH3)2], 31.65 [s, 1C, CH of 
CH3C(CH)2(CH)2CCH(CH3)2], 74.60 [t, 1C, CH of Cp], 70.24 [t, 1C, CH of Cp], 79.36 [t, 1C, CH of 
Cp], 75.81 [t, 1C, CH of Cp], 84.84 [virtual triplet, 1C, Quaternary C of Cp], 91.77 [t, 2C, CH of 
CH3C(CH)2(CH)2CCH(CH3)2], 97.29 [‘t’, 2C, CH of CH3C(CH)2(CH)2CCH(CH3)2], 100.08 [s, 1C, 
Quaternary C of CH3C(CH)2(CH)2CCH(CH3)2], 129.40, 129.20 [2t, 8C, m-CH of Ph], 132.97, 
131.61 [2s, 4C, p-CH Ph], 134.41 [t, 4C, o-CH of Ph], 134.92 [virtual triplet, 2C, Quaternary C 
of Ph], 136.24 [t, 4C, o-CH of Ph], 139.55 [virtual triplet, 2C, Quaternary C of Ph] ppm.  
31P{1H} NMR ((CD3)2CO, 121.49 MHz, 300 K): δ = 37.78 (s) ppm. 
ES MS (+): m/z 852.1 [M] – SbF6. 
 
5.2.4.2 Method 2 
 
To a suspension of [RuCl2(p-cymene)]2 (1) (159.2 mg, 0.260 mmol) in methanol (20 
cm3) were added NaSbF6 (134.5 mg, 0.520 mmol) and dppf (288.2 mg, 0.520 mmol). The 
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mixture was heated under reflux for 3 hours to yield an orange precipitate. It was filtered 
and washed with diethyl ether and water to yield the product as an orange powder. 
Yield: 435.8 mg, 0.411 mmol (79%) 
1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 0.88 [d, 
3
J(1H,1H) = 6.95 Hz,  6H, CH(CH3)2], 0.95 [s, 
3H, C6H4CH3], 2.63 [sept, 1H, CH(CH3)2],  4.07 [s, 2H, Cp], 4.27 [s, 2H, Cp], 4.35 [s, 2H, Cp], 
5.06 [s, 2H, Cp], 5.13 [d, 3J(1H,1H) = 6.16 Hz, 2H, η6-C6H4], 5.66 [‘d’,
 3
J(1H,1H) = 6.16 Hz, 2H, η6-
C6H4], 7.39-7.49, 7.52-7.63, 7.65-7.75 [3m, 20H, CH of Ph] ppm. 
 
5.2.5 Synthesis of [RuI(dppf)(p-cymene)]SbF6 – C44H42P2FeRul(SbF6) (5) 
 
To a suspension of [RuI2(p-cymene)]2 (2) (320.8 mg, 0.328 mmol) in a mixture of 
CH3OH/CH3CN (1:1, 20 cm
3) was added NaSbF6 (169.7 mg, 0.656 mmol). The mixture was 
stirred for 30 minutes to yield red wine color solution. After this time, dppf (379.8 mg, 0.685 
mmol) dissolved in THF (30 cm3) was added and left stirring for 1h. The solvent was removed 
in vacuo to give a dark red wine solid. It was washed with an ethanol/water (4:1) mixture 
and filtered. The solid was recrystallised from a mixture of acetone/ethanol (4:1) and 
washed with ethanol and water to afford a red wine color powder. 
Yield: 92.2 mg, 0.080 mmol (12%) 
Analysis for C44H42P2FeRul(SbF6) 
Found: C 49.95; H 4.00; I 22.45 % 
Calculated: C 45.86; H 3.67; I 11.01%  
1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 0.75 [d, 
3
J(1H,1H) = 6.95 Hz,  6H, CH(CH3)2], 1.05 [s, 
3H, C6H4CH3], 3.72 [m, 1H, CH(CH3)2],  4.12 [s, 2H, Cp], 4.21 [s, 2H, Cp], 4.39 [s, 2H, Cp], 5.38 
[d, 3J(1H,1H) = 6.36 Hz, 2H, η6-C6H4], 5.44 [s, 2H, Cp],  5.95 (d,
 3
J(1H,1H) = 6.36 Hz, 2H, η6-C6H4), 
7.39-7.45, 7.47-7.53, 7.54-7.60, 7.61-7.68 [4m, 20H, CH of Ph] ppm.  
13C{1H} NMR (CDCl3, 75.48 MHz, 300 K): δ = 15.16 [s, 1C, CH3 of CH3C(CH)2(CH)2CCH(CH3)2], 
21.34 [s, 2C, CH3 of CH3C(CH)2(CH)2CCH(CH3)2], 32.49 [s, 1C, CH of CH3C(CH)2(CH)2CCH(CH3)2], 
69.53 [t, 1C, CH of Cp], 73.29 [t, 1C, CH of Cp], 75.26 [t, 1C, CH of Cp], 79.31 [t, 1C, CH of Cp], 
91.67 [t, 2C, CH of CH3C(CH)2(CH)2CCH(CH3)2], 96.11 [s (br.), 2C, CH of 
CH3C(CH)2(CH)2CCH(CH3)2], 104.97 [s, 1C, Quaternary C of CH3C(CH)2(CH)2CCH(CH3)2], 128.28, 
128.42 [2t, 8C, m-CH of Ph], 130.90, 132.12 [2s, 4C, p-CH Ph], 133.92 [t, 4C, o-CH of Ph], 
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135.24 [t, 4C, o-CH of Ph], 135.81 [virtual triplet, 2C, Quaternary C of Ph], 140.15 [virtual 
triplet, 2C, Quaternary C of Ph] ppm.  
31P{1H} NMR (CDCl3, 121.49 MHz, 300 K): δ = 36.95 (s) ppm. 
ES MS (+): m/z 917.0 [M] – SbF6. 
 
5.2.6 Synthesis of [RuCl(dppf)(p-cymene)]BF4 – C44H42P2ClFeRu(BF4) (6) 
 
To a suspension [RuCl2(p-cymene)]2(1) (79.6 mg, 0.130 mmol) in methanol (10 cm
3) 
were added AgBF4 (50.6 mg, 0.260 mmol) and dppf (144.1 mg, 0.260 mmol). The mixture 
was heated under reflux for 2.5h to yield a yellow solution containing a white precipitate. It 
was filtered off and the solvent removed in vacuo to give an orange solid. It was dissolved in 
chloroform and a layer of pentane was added and left in the freezer overnight. Pentane was 
removed and the orange residue was washed with diethyl ether and water to afford a yellow 
powder. 
Yield: 79.3 mg, 0.087 mmol (33%) 
Analysis C44H42P2ClFeRu(BF4) 
Found: C 55.45; H 4.50; Cl 5.40*% 
Calculated: C 57.95; H 4.64; Cl 3.89 % 
* means that the sample used in the chlorine analysis is different from the sample used in 
the carbon and proton analysis but both samples belong to the same reaction. 
 1H NMR (CDCl3, 300.13 MHz, 300 K): δ = 0.88 [d, 
3
J(1H,1H) = 6.99 Hz,  6H, CH(CH3)2], 1.00 [s, 
3H, C6H4CH3], 2.64 [sept, 1H, CH(CH3)2],  4.06 [s, 2H, Cp], 4.26 [s, 2H, Cp], 4.35 [s, 2H, Cp], 
5.07 [s, 2H, Cp], 5.16 [d, 3J(1H,1H) = 6.04 Hz, 2H, η6-C6H4],   5.78 [‘d’,
 3
J(1H,1H) = 6.04 Hz, 2H, 
η
6-C6H4], 7.39-7.49, 7.53-7.63, 7.64-7.77 [3m, 20H, CH of Ph] ppm. 
13C{1H} NMR (CDCl3, 125.76 MHz, 300 K): δ = 14.73 [s, 1C, CH3 of CH3C(CH)2(CH)2CCH(CH3)2], 
20.72 [s, 2C, CH3 of CH3C(CH)2(CH)2CCH(CH3)2], 31.13 [s, 1C, CH of CH3C(CH)2(CH)2CCH(CH3)2], 
69.13 [t, 1C, CH of Cp], 73.74 [t, 1C, CH of Cp], 74.82 [t, 1C, CH of Cp], 78.67 [t, 1C, CH of Cp], 
83.86 [virtual triplet, 1C, Quaternary C of Cp], 90.83 [t, 2C, CH of CH3C(CH)2(CH)2CCH(CH3)2], 
96.34 [s, 2C, CH of CH3C(CH)2(CH)2CCH(CH3)2], 99.44 [s, 1C, Quaternary C of 
CH3C(CH)2(CH)2CCH(CH3)2], 128.55, 128.57 [2m, 8C, m-CH of Ph], 130.93, 132.32 [2s, 4C, p-
CH Ph], 133.16 [t, 4C, o-CH of Ph], 133.67 [virtual triplet, 2C, Quaternary C of Ph], 135.29 [t, 
4C, o-CH of Ph], 138.40 [virtual triplet, 2C, Quaternary C of Ph] ppm.  
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31P{1H} NMR (CDCl3, 121.49 MHz, 300 K): δ = 36.28 (s) ppm. 
ES MS (+): m/z 825.1 [M] – BF4. 
 
5.2.7 Synthesis of [RuCl(dppf)(p-cymene)]Cl – C44H42P2ClFeRu(Cl) (7) 
 
A mixture of [RuCl2(p-cymene)]2 (1) (153.1 mg, 0.250 mmol) and dppf (277.2 mg, 
0.500 mmol) in 8 mL of ethanol and 1 mL of benzene was heated at 55˚C for 50 min. It was 
left stirring overnight. The solvents were evaporated under reduced pressure. The resulting 
residue was dissolved in dichloromethane and diethyl ether was added to precipitate a light 
orange powder. The product was recrystallized from methanol-diethyl ether to afford a light 
orange powder. 
Yield: 221.9 mg, 0.258 mmol (>100%) 
Analysis C44H42P2ClFeRu(Cl) 
Found: C 58.80; H 5.00; 8.20 % 
Calculated: C 61.41; H 4.92; Cl 8.24 %    
 1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 0.89 [d, 
3
J(1H,1H) = 6.76 Hz,  6H, CH(CH3)2], 1.09 [s, 
3H, C6H4CH3], 2.67 [m, 1H, CH(CH3)2],  4.07 [s, 2H, Cp], 4.26 [s, 2H, Cp], 4.35 [s, 2H, Cp], 5.06 
[s, 2H, Cp], 5.18 [s (br.), 2H, η6-C6H4],   5.88 (s (br.), 2H, η
6-C6H4), 7.40-7.49, 7.55-7.64, 7.65-
7.77 [3m, 20H, CH of Ph] ppm.  
31P{1H} NMR (CDCl3, 121.49 MHz, 300 K): δ = 36.44 (s) ppm. 
ES MS (+): m/z 825.1 [M] – Cl. 
  
5.2.8 Synthesis of [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 – C76H62O2N2P4Cl3Ru2(SbF6) (8)     
 
To a suspension of [RuCl2(p-cymene)]2 (1) (200 mg, 0.328 mmol) in a mixture of 
CH3OH/CH3CN (1:1, 20 cm
3) was added NaSbF6 (169.7 mg, 0.656 mmol). The mixture was 
stirred for 30 minutes to yield an orange solution. After this time, DPEPhos (368.9 mg, 0.685 
mmol) dissolved in THF (30 cm3) was added and left stirring for 1h. The solvent was removed 
in vacuo to give a bright orange solid. It was washed with an ethanol/water (4:1) mixture and 
filtered. The solid was first recrystallised from ethanol to yield a yellow powder which was 
after recrystallised from methanol to afford a powder in the same color. 
Yield: 67.7 mg, 0.040 mmol (6%) 
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Analysis for C76H62O2N2P4Cl3Ru2(SbF6) 
Found: C 53.30; H 3.65; N 1.50; Cl 6.65* % 
 Calculated: C 53.59; H 3.67; N 1.64; Cl 6.24 % 
* means that the sample used in the chlorine analysis is different from the sample used in 
the carbon and proton analysis but both samples belong to the same reaction. 
1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 1.64 [s (br.), 6H, NCCH3], 6.38-7.81 (m, 62H, 
DPEPhos).  
13C{1H} NMR (CDCl3, 75.47 MHz, 300 K): more NMR experiments needed to correctly assign 
all the peaks (spectrum shown in the appendix 8.1). 
ES MS (+): m/z 1469.1 [MH+] – SbF6. 
 
5.2.9 Synthesis of [RuCl(P(n-Bu)3)2(p-cymene)]SbF6 – C34H68P2ClRu(SbF6) (9)           
 
To a suspension of [RuCl2(p-cymene)]2 (1) (79.6 mg, 0.130 mmol) in methanol (10cm
3) 
were added NaSbF6 (67.3 mg, 0.260 mmol) and P(n-Bu)3 (0.24 cm
3, 0.970 mmol). The 
mixture was heated under reflux for 2 hours to yield a yellow/orange solution containing a 
white precipitate. It was filtered off and the solvent removed under reduced pressure. The 
resulting residue was dissolved in chloroform and a layer of pentane was added and left in 
the freezer overnight. Pentane was removed and the orange powder obtained was washed 
with diethyl ether and water to afford crystalline orange clusters. 
Yield: 30.2 mg, 0.0331 mmol (13%) 
Analysis for C34H68P2ClRu(SbF6) 
Found: C 44.55; H 7.55; Cl 3.75 % 
Calculated: C 44.82; H 7.52; Cl 3.89 % 
1H NMR (CDCl3, 500.23 MHz, 297 K): δ = 0.96 [t, 18H, CH3CH2CH2CH2-], 1.28 [d, 
3
J(1H,1H) = 
6.95 Hz,  6H, CH(CH3)2], 1.38-1.47 [m, 18H, CH2 of n-Bu], 1.47-1.55 [m, 6H, CH2 of n-Bu], 1.74-
1.85 [m, 6H, CH2 of n-Bu], 2.04 [s, 3H, C6H4CH3], 2.05-2.14 [m, 6H, CH2 of n-Bu], 2.64 [sept, 
1H, CH(CH3)2], 5.60 [d,
 3
J(1H,1H) = 6.16 Hz, 2H, η6-C6H4],   6.03 [‘d’,
 3
J(1H,1H) = 6.16 Hz, 2H, η6-
C6H4] ppm.  
13C{1H} NMR (CDCl3, 125.76 MHz, 300 K): δ = 13.85 [s, 6C, CH3CH2CH2CH2-], 18.36 [s, 1C, CH3 
of CH3C(CH)2(CH)2CCH(CH3)2], 21.77 [s, 2C, CH3 of CH3C(CH)2(CH)2CCH(CH3)2], 24.52 [t, 6C, 
CH3CH2CH2CH2-], 26.40  [t, 6C, CH3CH2CH2CH2-], 28.42 [t, 6C, CH3CH2CH2CH2-], 31.33 [s, 1C, 
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CH of CH3C(CH)2(CH)2CCH(CH3)2], 86.45 [t, 2C, CH of CH3C(CH)2(CH)2CCH(CH3)2], 95.81 [s, 2C, 
CH of CH3C(CH)2(CH)2CCH(CH3)2] ppm.  
31P{1H} NMR (CDCl3, 121.49 MHz, 300 K): δ = 14.09 [s, major peak], 31.44 [s, small peak] 
ppm. 
ES MS (+): m/z 675.4 [M] – SbF6. 
 
5.2.10 Synthesis of [RuI(P(n-Bu)3)2(p-cymene)]SbF6 – C34H68P2IRu(SbF6) (10)           
 
To a suspension of [RuI2(p-cymene)]2 (2) (127.2 mg, 0.130 mmol) in methanol (10cm
3) 
were added NaSbF6 (67.3 mg, 0.260 mmol) and P(n-Bu)3 (0.24 cm
3, 0.970 mmol). The 
mixture was heated under reflux for 3.5h to yield a light red solution containing a white 
precipitate. It was filtered off and the solvent removed under reduced pressure. The 
resulting residue was dissolved in chloroform and a layer of pentane was added and left in 
the freezer overnight. Pentane was removed and the dark red residue obtained was washed 
with diethyl ether and water to afford a red wine color powder. 
Yield:  125.6 mg, 0.125 mmol (48%) 
Analysis for C34H68P2IRu(SbF6) 
Found: C 42.80; H 7.40 % 
Calculated: C 40.73; H 6.84 %          
1H NMR (CDCl3, 500.23 MHz, 299 K): δ = 0.93-1.01 [m, 18H, CH3CH2CH2CH2], 1.29 [d, 
3
J(1H,1H) 
= 6.95 Hz,  6H, CH(CH3)2], 1.40-1.50 [m, 18H, CH2 of n-Bu], 1.50-1.57 [m, 6H, CH2 of n-Bu], 
1.88-1.99 [m, 6H, CH2 of n-Bu], 2.18-2.29 [m, 6H, CH2 of n-Bu], 2.29 [s, 3H, C6H4CH3], 3.21 
[sept, 1H, CH(CH3)2], 5.63 [d,
 3
J(1H,1H) = 6.16 Hz, 2H, η6-C6H4],   6.37 [‘d’,
 3
J(1H,1H) = 6.16 Hz, 
2H, η6-C6H4] ppm.  
13C{1H} NMR more NMR experiments needed to correctly assign all the peaks (spectrum 
shown in the appendix 10.1) 
1P{1H} NMR (CDCl3, 121.49 MHz, 300 K): δ = 11.53 [s, major peak], 31.57 [s, medium size 
peak], 36.23 [s, small peak] ppm. 
ES MS (+): m/z 767.3 [M] – SbF6.  
 
 
 
p-Cymene Based Ruthenium Complexes as Catalysts 
69 
Joel David Avelino Fonseca 
5.2.11 Synthesis of [RuCl(P(i-Bu)3)2(p-cymene)]SbF6 – C34H68P2ClRu(SbF6) (11)     
 
To a suspension of [RuCl2(p-cymene)]2 (1) (79.6 mg, 0.130 mmol) in methanol (10cm
3) 
were added NaSbF6 (67.3 mg, 0.260 mmol) and P(i-Bu)3 (0.24 cm
3, 0.970 mmol). The mixture 
was heated under reflux for 3h to yield a red/brown solution. The solvent was removed 
under reduced pressure. The resulting residue was dissolved in chloroform and diethyl ether 
was added. A yellow precipitate was formed straight away and filtered. It was washed with 
diethyl ether and water to afford fine yellow needles in 26% yield (62.6 mg, 0.069 mmol). 
Yield: 62.6 mg, 0.069 mmol (26%) 
Analysis for C34H68P2ClRu(SbF6) 
Found: C 44.30; H 7.50; Cl 3.55* % 
Calculated: C 44.82; H 7.52; Cl 3.89 % 
* means that the sample used in the chlorine analysis is different from the sample used in 
the carbon and proton analysis but both samples belong to the same reaction. 
1H NMR (CDCl3, 500.23 MHz, 298 K): δ = 1.08 [d,
 3
J(1H,1H) = 6.36 Hz, 18H, (CH3)2CHCH2CH2], 
1.14 [d, 3J(1H,1H) = 6.56 Hz, 18H, (CH3)2CHCH2CH2], 1.29 [d, 
3
J(1H,1H) = 6.95 Hz,  6H, CH(CH3)2], 
1.80-1.89 [m, 6H, (CH3)2CHCH2-], 2.06-2.20 [m, 12H, (CH3)2CHCH2-], 2.62 [sept, 1H, CH(CH3)2], 
5.65 [d, 3J(1H,1H) = 6.16 Hz, 2H, η6-C6H4],   5.92 [‘d’,
 3
J(1H,1H) = 6.16 Hz, 2H, η6-C6H4] ppm.  
13C{1H} NMR more NMR experiments needed to correctly assign all the peaks (spectrum 
shown in the appendix 11.1) 
1P{1H} NMR (CDCl3, 202.46 MHz, 299 K): δ = 0.06 [s, small peak], 18.19 [s, major peak], 28.87 
[s, small peak] ppm. 
ES MS (+): m/z 675.4 [M] – SbF6. 
 
5.2.12 Synthesis of [RuCl2P(i-Bu)3(p-cymene)] – C22H41PCl2Ru (12)                        
 
To a suspension of [RuCl2(p-cymene)]2 (1) (79.6 mg, 0.130 mmol) in methanol (10cm
3) 
were added NaSbF6 (67.3 mg, 0.260 mmol) and P(i-Bu)3 (0.13 cm
3, 0.520 mmol). The mixture 
was heated under reflux for 3.50h to yield a red/brown solution. The solvent was removed 
under reduced pressure. The resulting residue was dissolved in chloroform and a layer of 
pentane was added and left in the freezer overnight. Both a brownish red powder and a 
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yellow powder were obtained. The brownish red powder was recrystallized from acetone to 
afford a powder in the same color. No yield was calculated, but it was low.  
Analysis for C22H41PCl2Ru 
Found: C 51.60; H 8.10; 14.20* % 
Calculated: C 51.96; H 8.13; Cl 13.94 % 
* means that the sample used in the chlorine analysis is different from the sample used in 
the carbon and proton analysis but both samples belong to the same reaction. 
1H NMR (CDCl3, 300.13 MHz, 300 K): δ = 1.05 [d,
 3
J(1H,1H) = 6.42 Hz, 18H, (CH3)2CHCH2-], 1.28 
[d, 3J(1H,1H) = 6.99 Hz,  6H, CH(CH3)2], 1.99-2.07 [m, 6H, (CH3)2CHCH2-], 2.07-2.21 [m, 3H, 
(CH3)2CHCH2-], 2.10 [s, 3H, C6H4CH3], 2.86 [sept, 1H, CH(CH3)2], 5.30 [d,
 3
J(1H,1H) = 5.67 Hz, 
2H, η6-C6H4],   5.43 [d,
 3
J(1H,1H) = 5.67 Hz, 2H, η6-C6H4] ppm. 
ES MS (+): m/z 473.2 [M] – Cl. 
 
5.2.13 Synthesis of [RuCl2P(n-Bu)3(p-cymene)] – C22H41PCl2Ru (13)             
 
To a suspension of [RuCl2(p-cymene)]2 (1) (159.2 mg, 0.260 mmol) in methanol 
(20cm3) was added P(n-Bu)3 (0.13 cm
3, 0.520 mmol). The mixture was stirred for 30 min. The 
solvent was removed under reduced pressure. The resulting residue was dissolved in 
chloroform and diethyl ether was added to precipitate a red powder. It was filtered and 
washed with diethyl ether to afford a red product. 
Yield: 158.5 mg, 0.312 mmol (60%) 
 1H NMR (CDCl3, 300.13 MHz, 300 K): δ = 0.92 [t, 9H, CH3CH2CH2CH2], 1.24 [d, 
3
J(1H,1H) = 6.89 
Hz,  6H, CH(CH3)2], 1.31-1.54 [m, 12H, CH2 of n-Bu], 1.92-2.04 [m, 6H, CH2 of n-Bu], 2.07 [s, 
3H, C6H4CH3], 2.83 [sept, 1H, CH(CH3)2], 5.38 [d,
 3
J(1H,1H) = 6.23 Hz, 2H, η6-C6H4],   5.42 [d,
 
3
J(1H,1H) = 6.23 Hz, 2H, η6-C6H4] ppm. 
ES MS (+): m/z 473.2 [M] – Cl. 
 
5.2.14 Synthesis of [RuCl(P(CH3)3)2(p-cymene)]SbF6 – RuC16H32P2Cl(SbF6) (14) 
 
To a suspension of [RuCl2(p-cymene)]2 (1) (79.6 mg, 0.130 mmol) in methanol (10cm
3) 
were added NaSbF6 (67.3 mg, 0.260 mmol) and P(CH3)3 (0.10 cm
3, 0.970 mmol). The mixture 
was heated under reflux for 3h to yield yellow solution containing a white precipitate. It was 
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filtered off and the solvent removed under reduced pressure. The resulting residue was 
dissolved in chloroform and diethyl ether was added to precipitate a yellow powder. It was 
washed with diethyl ether and water to afford a powder in the same color. 
Yield: 44.4 mg, 0.067 mmol (26%) 
Analysis for RuC16H32P2Cl(SbF6) 
Found: C 32.45; H 5.60 % 
Calculated: C 29.18; H 4.90 %  
1H NMR (CDCl3, 500.23, 299 K MHz): δ = 1.24 [d, 6H, 
3
J(1H,1H) = 6.95 Hz, 6H, CH(CH3)2], 1.70 
[t, 18H, (CH3)3], 2.16 [s, 3H, C6H4CH3], 2.67 [sept, 1H, CH(CH3)2], 5.76 [d,
 3
J(1H,1H) = 5.96 Hz, 
2H, η6-C6H4],   6.44 [‘d’,
 3
J(1H,1H) = 5.96 Hz, 2H, η6-C6H4] ppm.  
1P{1H} NMR (CDCl3, 121.49 MHz, 300 K): δ = 2.93 (s) ppm. 
ES MS (+): m/z 423.1 [M] – SbF6. 
 
5.2.15 Synthesis of [RuCl2PPh(OCH3)2(p-cymene)] – [RuC18H25PO2Cl2] (15) 
 
To a suspension of [RuCl2(p-cymene)]2 (1) (79.6 mg, 0.130 mmol) in methanol (10cm
3) 
were added NaSbF6 (67.3 mg, 0.260 mmol) and PhPCl2 (0.13 cm
3, 0.960 mmol). The mixture 
was heated under reflux for 3.5h to yield a red wine color solution. The solvent was removed 
under reduced pressure and the resulting residue was dissolved in chloroform and a layer of 
pentane added and left in the freezer overnight. Pentane was removed and diethyl ether 
was added to precipitate a red wine color powder. It was washed with diethyl ether and 
water to yield a powder in the same color.  
Yield: 100.9 mg, 0.212 mmol (82% yield) 
1H NMR (CDCl3, 500.23 MHz, 299 K): δ = 1.07 [d, 6H, 
3
J(1H,1H) = 6.95 Hz, 6H, CH(CH3)2],  1.92 
[s, 3H, C6H4CH3], 2.69 [sept, 1H, CH(CH3)2], 3.79, 3.82 [2s, 6H,  OCH3], 5.24 [d,
 3
J(1H,1H) = 5.96 
Hz, 2H, η6-C6H4],   5.29  [‘d’,
 3
J(1H,1H) = 5.96 Hz, 2H, η6-C6H4] ppm. 
ES MS (+): m/z 441.0 [M] – Cl. 
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5.3 Catalytic Reactions 
  
5.3.1 Redox Neutral Alkylations 
 
 For in situ generated catalysts: [RuX2(p-cymene)]2 (0.0459 g X=Cl or 0.733 g X=I,  
0.075 mmol) and the phosphine ligand (0.15 mmol for bidentade phosphines or 0.30 mmol 
for monodentate) were placed in a round bottom flask. tert-Butylamine (0.32 mL, 3 mmol), 
phenethyl alcohol (0.36 mL, 3 mmol) and toluene (10 mL) were added dropwise. The 
reaction mixture was allowed to stir and heated at reflux for 24 hours. It was filtered 
through celite and washed with dichloromethane, the filtrate collected and solvents 
evaporated in vacuo. An NMR of the oily residue obtained is acquired to figure out the 
conversions. The product (t-butyl(2-phenylethyl)amine) obtained employing the [RuCl2(p-
cymene)]2(1)-dppf pair was isolated together with phenethyl alcohol by distillation under 
reduced pressure to yield a pale yellow liquid. 1H NMR (CDCl3, 500.23 MHz, 300 K): δ = 1.01 
[s, 9H, NH(CH3)3], 2.69-2.74 (m, 2H, CH2], 2.74-2.79 [m, 2H, CH2], 7.10-7.25 [m, 5H, C6H5] 
ppm. This is consistent with literature data.24, 64 
 When ruthenium monomers were used, no phosphine ligand was added to the 
reaction pot. 0.0375 mmol of the monomer were used for S/C ratios of 40 and 0.075 mmol 
for S/C ratios of 20. 
  
5.3.1.1 1H NMR Analysis 
 
As said before, in the model N-alkylation of this project there is often the formation 
of appreciable quantities of PhCH2CH2O2CCH2Ph so, where present, the conversions 
accounted this fact. If both the alcohol and ester peaks are present, the product conversion 
is calculated by manually integrating the alcohol peak against the product and ester peaks. If 
only the ester peak is present, the product conversion is calculated integrating the ester 
peak against the product peak. An example of how these conversions were calculated is 
shown bellow for the monomer 7 (integrals are found in figure 2.12). 
After the integrations are done, there is the normalization of each peak where each 
integral is divided by the number of protons corresponding to that peak. But since the ester 
is formed by two molecules of alcohol, the ester integral still needs to be multiplied by two. 
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Then to calculate a specific conversion it is necessary to divide its value obtained after 
normalization by the sum of all normalized results and multiply by 100. The equations for 
the alcohol, amine and ester are: 
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5.3.1.2 Gas Chromatography Analysis 
 
 Every sample submitted to GC analysis was made up of 20 µL of the substance being 
analysed (starting material or reaction mixture) and 4 µL of decane as internal standard. All 
of them were also diluted with 2 mL of acetonitrile. The 20 and the 4 µL were measured with 
a 25 ± 0.25 µL micropipette. In the catalytic reactions, the same procedure of 5.3.1 was 
followed but now taking from time to time 20 µL of the reaction mixture. The GC samples 
were prepared as described above and since they were only analysed hours later, they were 
immediately stored in the freezer for a couple of hours in order to extinguish the reaction. 
The concentration of the starting alcohol and of the product was obtained using the internal 
standard method described in the literature65 and a summary of it is shown bellow. The 
actual procedure was adapted from the one used in the Process Lab of the School of 
Chemistry. 
 The internal standard method uses an internal standard which is a known amount of 
a compound, in the present case decane, different from the analyte (t-butyl(2-
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phenylethyl)amine), which is added to the unknown. Then the signal from the analyte is 
compared with the signal from the internal standard to find out how much analyte is 
present. Internal standards are specially usefull for analyses in which the quantity of sample 
analysed or the instrument response varies slightly from run to run for reasons that are 
difficult to control. 
 Initially it is necessary to measure the relative response of the detector to the 
standard and analyte. Usually a known mixture of standard and analyte is prepared with 
known concentrations of both, but since the analyte in this project is not commercially 
available and the one obtained in here is mixed with some alcohol, another strategy was 
followed. Two solutions were prepared. One made up of 20 µL of alcohol, 4 µL of decane and 
2 mL of acetonitrile and another one made up of 20 µL of the mixture product-alcohol, 4 µL 
of decane and 2 mL of acetonitrile. From the first one the internal response factor of the 
alcohol (IRF) was calculated as follows: 
 
ℎ 

[ℎ] = "#$%&'()(& *
+

 

[+

] , ⟺ "#$%&'()(& =
ℎ 
 × [+

]
[ℎ] × +

 
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Using the IRF found for the alcohol, the alcohol concentration in second solution was 
calculated from respective the GC data using the equation above. By the product:alcohol 
ratio found in the product-alcohol mixture by 1H NMR, the product concentration in the 
second solution was extrapolated from the alcohol concentration found. After finding the 
product concentration in the second solution, the product IRF was calculated as follows: 
 
"#$./(01'2 = 	+3 
 × [+

][	+3] × +

 
 
 
Using the product and decane area found from every GC sample of the N-alkylation reaction, 
the product concentration was calculated using the following equation: 
 
[	+3] = 	+3 
 × [+

]"#$./(01'2 × +

 
 
p-Cymene Based Ruthenium Complexes as Catalysts 
75 
Joel David Avelino Fonseca 
Since the product was diluted from 20 µL (reaction) to 2 mL (GC vial), the concentration of 
product in the reaction pot was obtained by multiplying the concentration of product found, 
by the inverse of the dilution factor, this is (2×10-3∕20×10-6). To obtain the conversions the 
following equation was employed: 
4
./(01'2(%) = [	+3][ℎ]2789:; × 100 
  
5.3.2 Transfer Hydrogenations 
 
Both reductions (acetophenone and benzaldehyde) were carried out using the same 
general procedure.66 The pre-catalyst dimer-ligand pair (0.005 mmol of dimer, 0.010 mmol 
of bidentate phosphine) or the monomer (0.010 mmol) was placed in a carousel tube. 9 mL 
of isopropanol were added and the mixture left stirring. After 15 minutes, 1.01 mg (0.009 
mmol) of t-BuOK dissolved in 1mL of isopropanol were added dropwise. The reaction 
mixture was stirred at 60 ˚C for 1h. Then, acetophenone (0.12 mL, 1 mmol) or benzaldehyde 
(0.10 mL, 1mmol) was added and the mixture left to stir at 60 ˚C for more 20h (S/C ratio of 
100:1). The reactions were set under normal atmosphere with the refrigeration system 
turned on. To get the conversions, the resulting solutions were evaporated in vacuo and the 
oily residue obtained submitted to 1H NMR analysis. Conversions were calculated as shown 
for the N-alkylations, by manually integrating a characteristic substrate 
(acetophenone/benzaldehyde) peak against the product peak. No side product was 
considered (substrate:product ratio equal to 1). Peaks chosen are shown in figure 2.15 and 
2.17). 
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APPENDIX 1 – 1H NMR spectrum of [RuCl2(p-cymene)]2 (1) in CDCl3 
 
Acquisition Time (sec) 1.1698 Comment Full Name Joel Fonseca Room No. 1.29 Sample jdaf1.1 Date 12 Nov 2010 15:21:36
Date Stamp 12 Nov 2010 15:21:36 File Name F:\Leeds Spectra\JDAF1.1\10\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 8192 Owner gen Points Count 16384 Pulse Sequence zg30
Receiver Gain 362.00 SW(cyclical) (Hz) 7002.80 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2725.3328 Spectrum Type STANDARD Sweep Width (Hz) 7002.37 Temperature (degree C) 27.000
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APPENDIX 2 – 1H NMR spectrum of [RuI2(p-cymene)]2 (2) in CDCl3 
 
Acquisition Time (sec) 1.1698 Comment Full Name Joel Fonseca Room No. 1.29 Sample jdaf2 Date 09 Nov 2010 11:37:36
Date Stamp 09 Nov 2010 11:37:36 File Name C:\Users\Joel Fonseca\Desktop\LAB WORK\Leeds Spectra\JDAF2\10\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 8192 Owner gen Points Count 16384 Pulse Sequence zg30
Receiver Gain 362.00 SW(cyclical) (Hz) 7002.80 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2725.3325 Spectrum Type STANDARD Sweep Width (Hz) 7002.37 Temperature (degree C) 27.000
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APPENDIX 3 – 1H NMR spectrum of [RuBr2(p-cymene)]2 (3) in CDCl3 
 
Acquisition Time (sec) 1.1698 Comment Full Name Joel Fonseca Room No. 1.29 Sample jdaf3 Date 10 Nov 2010 10:18:40
Date Stamp 10 Nov 2010 10:18:40 File Name C:\Users\Joel Fonseca\Desktop\LAB WORK\Leeds Spectra\JDAF3\1\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 8192 Owner gen Points Count 16384 Pulse Sequence zg30
Receiver Gain 362.00 SW(cyclical) (Hz) 7002.80 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2724.9050 Spectrum Type STANDARD Sweep Width (Hz) 7002.37 Temperature (degree C) 27.000
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APPENDIX 4 – 1H NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) in (CD3)2CO 
 
Acquisition Time (sec) 2.5166 Comment Full Name Joel Fonseca Room No. 1.29 Sample jdaf15_2nd_pp_recris
Date 24 Feb 2011 10:42:08 Date Stamp 24 Feb 2011 10:42:08
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Solvent Acetone Spectrum Offset (Hz) 2739.4031 Spectrum Type STANDARD Sweep Width (Hz) 6510.22
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APPENDIX 4.1 – 1H NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name Joel Fonseca Room No. 1.29 Sample jdaf15_2nd_CDCl3
Date 07 Mar 2011 18:12:16 Date Stamp 07 Mar 2011 18:12:16
File Name F:\Leeds Spectra\jdaf15_2nd_CDCl3\10\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 256.00 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2739.6184 Spectrum Type STANDARD
Sweep Width (Hz) 6510.22 Temperature (degree C) 27.000
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APPENDIX 4.2 – 13C{1H} NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) in (CD3)2CO 
Acqu is ition T ime (sec ) 0.9306 Comment Name : Joel Fonseca Roo/Lab : 1.29 Sample : jda15-2nd C44 H42 P2 Fe C l Ru Sb F6 NMR serv ice
Date 11 Mar 2011 19:07:44 Date  S tamp 11 Mar 2011 19:07:44
F ile  Name F:\Leeds Spectra\jdaf15-2nd.INO \10\PDATA\1\1r Frequency  (MHz ) 125.76 Nuc leus 13C
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Po ints  C oun t 131072 Pu lse Sequence zgpg30 Receive r Ga in 9195.20 SW (cyc lica l)  (H z ) 35211.27
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APPENDIX 4.3 – DEPT 13C{1H} NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) in (CD3)2CO 
Acquisition Time (sec) 1.0813 Comment Name.- Joel D. Fonseca Room/Lab No.- 1.29 Sample.- R15 2nd C44 H42 Fe RuCl Sb F6 NMR service
Date 25 Feb 2011 18:29:20 Date Stamp 25 Feb 2011 18:29:20
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Owner gen Points Count 262144 Pulse Sequence dept135 Receiver Gain 6502.00
SW(cyclical) (Hz) 30303.03 Solvent Acetone Spectrum Offset (Hz) 13283.0537 Spectrum Type DEPT135
Sweep Width (Hz) 30302.92 Temperature (degree C) 27.000
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APPENDIX 4.4 – HMQC NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) in (CD3)2CO 
A c q u is i t io n  T im e  ( s e c ) ( 0 .1 6 2 0 ,  0 .0 0 5 0 ) C o m m e n t 5  m m  B B I 1 H -B B  Z -G R D  Z 8 1 0 7 /0 1 9 9
D a t e 1 1  M a r  2 0 1 1  1 7 :4 6 :0 0 F i l e  N a m e F : \L e e d s  S p e c t r a \ jd a f1 5 _ 2 n d _ C & H \1 2 \P D A T A \1 \2 r r
F r e q u e n c y  ( M H z ) ( 5 0 0 .2 3 ,  1 2 5 .7 9 ) N u c le u s ( 1 H ,  1 3 C )
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
F2 Chemical Shift (ppm)
16
24
32
40
48
56
64
72
80
88
96
104
112
120
128
136
F
1
 
C
h
e
m
i
c
a
l
 
S
h
i
f
t
 
(
p
p
m
)
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APPENDIX 4.5 – COSY NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) in (CD3)2CO 
A c q u is it io n  T im e  ( s e c ) (0 .2 630 , 0 .0 411 ) C om m e n t 5  m m  Q N P   1H /1 3C /11B /3 1P  Z -g rad  Z 5626 /0001
D a te 01  M a r 2011  1 6 :4 7 :00
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S o lv e n t A c e to ne S p e c t ru m  T y p e C O SY
S w e e p  W id th  (H z ) (3 8 92 .1 8 , 3 890 .28 ) T em p e ra tu re  ( d e g re e  C ) 27 .000
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APPENDIX 4.6 – 31P{1H} NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) in (CD3)2CO 
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APPENDIX 4.7 – Mass spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 1) 
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APPENDIX 4.8 – 1H NMR spectrum of [RuCl(dppf)(p-cymene)]SbF6 (4) (method 2) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf76 Date 01 Aug 2011 11:54:56
Date Stamp 01 Aug 2011 11:54:56 File Name F:\Leeds Spectra\jdaf76\10\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 16384 Owner nmr Points Count 32768 Pulse Sequence zg30
Receiver Gain 256.00 SW(cyclical) (Hz) 6510.42 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2740.7151 Spectrum Type STANDARD Sweep Width (Hz) 6510.22 Temperature (degree C) 27.000
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APPENDIX 5 – 1H NMR spectrum of [RuI(dppf)(p-cymene)]SbF6 (5) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf17_protons
Date 21 Mar 2011 11:09:52 Date Stamp 21 Mar 2011 11:09:52
File Name F:\Leeds Spectra\jdaf17_protons\10\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 181.00 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2734.7197 Spectrum Type STANDARD
Sweep Width (Hz) 6510.22 Temperature (degree C) 27.000
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APPENDIX 5.1 – 13C{1H} NMR spectrum of [RuI(dppf)(p-cymene)]SbF6 (5) in CDCl3 
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APPENDIX 5.2 – 31P{1H} NMR spectrum of [RuI(dppf)(p-cymene)]SbF6 (5) in CDCl3 
 
Acquis ition  T ime  (s ec ) 0.6685 Comment Name- Joel Fonseca Room No- 1.29 Sample- jdaf17_new_31P
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APPENDIX 5.3 – Mass spectrum of [RuI(dppf)(p-cymene)]SbF6 (5) 
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APPENDIX 6 – 1H NMR spectrum of [RuCl(dppf)(p-cymene)]BF4 (6) in CDCl3 
 
Acquisition Time (sec) 5.2953 Comment Name- Joel Fonseca Room No- 1.29 Sample- jdaf25 Date 07 Jun 2011 12:29:04
Date Stamp 07 Jun 2011 12:29:04 File Name F:\Leeds Spectra\jdaf25\10\PDATA\1\1r
Frequency (MHz) 300.13 Nucleus 1H Number of Transients 32 Origin spect
Original Points Count 32768 Owner nmr Points Count 65536 Pulse Sequence zg30
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APPENDIX 6.1 – 13C{1H} NMR spectrum of [RuCl(dppf)(p-cymene)]BF4 (6) in CDCl3 
 
Acquis ition  T ime (sec ) 0.6980 Comment Name.- Joel Fonseca Room/Lab No.- 1.29 Sample.- JDAF 25 RuCl(C34 H28 Fe P2) C10 H14 BF4 NMR service
Date 10 Jun 2011 16:30:08 Date S tamp 10 Jun 2011 16:30:08
F ile  Name F:\Leeds Spectra\jdaf25.INO\10\PDATA\1\1r Frequency  (MHz ) 125.76 Nuc leus 13C
Number of T rans ients 24576 Orig in drx500 O rig inal Points  Count 24576 Owner gen
Points  Count 131072 Pulse Sequence zgpg30 Receiver Gain 9195.20 SW (cyc lica l) (Hz ) 35211.27
Solven t CHLOROFORM-d Spec trum  O ffset (Hz ) 15058.1514 Spec trum  Type STANDARD Sweep W idth (H z) 35211.00
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APPENDIX 6.2 – 31P{1H} NMR spectrum of [RuCl(dppf)(p-cymene)]BF4 (6) in CDCl3 
 
Acquis ition T ime  (sec ) 0.6685 Comment Name- Joel Fonseca Room No- 1.29 Sample- jdaf25_new_31P
Date 05 Aug 2011 12:18:24 Date  S tamp 05 Aug 2011 12:18:24
F ile  Name F:\Leeds Spectra\jdaf25_new_31P\10\PDATA\1\1r Frequency  (MHz ) 121.49 Nuc leus 31P
Number o f T rans ients 160 O rig in spect O rig inal Po in ts  C oun t 32768 Owner nmr
Po ints  Count 65536 Pu lse Sequence zgpg30 Receive r G a in 2050.00 SW (cyc lica l)  (H z) 49019.61
So lvent CHLOROFORM-d Spec trum  O ffset (H z ) -0.0039 Spec trum  Type STANDARD
Sweep W idth  (H z) 49018.86 Temperature (degree C ) 26.983
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APPENDIX 7 – 1H NMR spectrum of [RuCl(dppf)(p-cymene)]Cl (7) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf45_recrys
Date 06 Jul 2011 15:56:00 Date Stamp 06 Jul 2011 15:56:00
File Name F:\Leeds Spectra\jdaf45_recrys\10\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 256.00 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2734.5208 Spectrum Type STANDARD
Sweep Width (Hz) 6510.22 Temperature (degree C) 27.000
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APPENDIX 7.1 – 31P{1H} NMR spectrum of [RuCl(dppf)(p-cymene)]Cl (7) in CDCl3 
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APPENDIX 7.2 – Mass spectrum of [RuCl(dppf)(p-cymene)]Cl (7) 
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APPENDIX 8 – 1H NMR spectrum of [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf18_recrys
Date 13 Apr 2011 15:21:52 Date Stamp 13 Apr 2011 15:21:52
File Name F:\Leeds Spectra\jdaf18_2nd_recrys (5)\20\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 512.00 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2734.3459 Spectrum Type STANDARD
Sweep Width (Hz) 6510.22 Temperature (degree C) 27.000
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APPENDIX 8.1 – 13C{1H} NMR spectrum of [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) in CDCl3 
 
Acqu is it ion  T ime (s ec ) 0.8039 Comment Name- Joel Fonseca Room No- 1.29 Sample- jdaf18_13C Date 12 May 2011 00:55:44
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APPENDIX 8.2 – Mass spectrum of [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) 
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APPENDIX 9 – 1H NMR spectrum of [RuCl(P(n-Bu)3)2(p-cymene)]SbF6 (9) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf21_protons
Date 01 Jun 2011 20:01:20 Date Stamp 01 Jun 2011 20:01:20
File Name F:\Leeds Spectra\jdaf21_protons\10\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 456.10 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2736.1270 Spectrum Type STANDARD
Sweep Width (Hz) 6510.22 Temperature (degree C) 24.200
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APPENDIX 9.1 – 13C{1H} NMR spectrum of [RuCl(P(n-Bu)3)2(p-cymene)]SbF6 (9) in CDCl3 
 
Acqu is ition  T ime (sec ) 0.6980 Comment Name.- Joel Fonseca Room/Lab No.- 1.29 Sample.- JDAF 21 RuCl(C12 H27 P)2 C10 H14 NMR serv ice
Date 09 Jun 2011 19:16:32 Date S tamp 09 Jun 2011 19:16:32
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APPENDIX 9.2 – 31P{1H} NMR spectrum of [RuCl(P(n-Bu)3)2(p-cymene)]SbF6 (9) in CDCl3 
 
Acquisition Time (sec) 0.6685 Comment Name- Joel Fonseca Room No- 1.29 Sample- jdaf21_31P Date 03 Jun 2011 12:01:20
Date Stamp 03 Jun 2011 12:01:20 File Name F:\Leeds Spectra\jdaf21_31P\10\PDATA\1\1r
Frequency (MHz) 121.49 Nucleus 31P Number of Transients 160 Origin spect
Original Points Count 32768 Owner nmr Points Count 65536 Pulse Sequence zgpg30
Receiver Gain 2050.00 SW(cyclical) (Hz) 49019.61 Solvent CHLOROFORM-d
Spectrum Offset (Hz) -0.0039 Spectrum Type STANDARD Sweep Width (Hz) 49018.86 Temperature (degree C) 26.933
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APPENDIX 9.3 – Mass spectrum of [RuCl(P(n-Bu)3)2(p-cymene)]SbF6 (9) 
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APPENDIX 10 – 1H NMR spectrum of [RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf24 Date 03 Jun 2011 14:07:12
Date Stamp 03 Jun 2011 14:07:12 File Name F:\Leeds Spectra\jdaf24\10\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 16384 Owner nmr Points Count 32768 Pulse Sequence zg30
Receiver Gain 322.50 SW(cyclical) (Hz) 6510.42 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2734.7197 Spectrum Type STANDARD Sweep Width (Hz) 6510.22 Temperature (degree C) 25.400
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APPENDIX 10.1 – 13C{1H} NMR spectrum of [RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) in CDCl3 
 
A cqu is it ion  T im e  (s ec ) 0.5603 C omm en t Name.- Joel Fonseca Room /Lab No.- 1.29  Sample.- jdaf 24 R uI(C42 H27 P )2 C10H14 NMR  serv ice
D a te 08 Jun 2011 16:38:40 D a te  S tam p 08 Jun 2011 16 :38:40
F ile  N am e F:\Leeds Spec tra\jdaf24.INO \12\PDATA\1\1r F requen c y  (MH z ) 125.76 Nuc leus 13C
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APPENDIX 10.2 – Mass spectrum of [RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) 
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APPENDIX 11 – 1H NMR spectrum of [RuCl(P(i-Bu)3)2(p-cymene)]SbF6 (11) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf26.1
Date 09 Jun 2011 11:20:48 Date Stamp 09 Jun 2011 11:20:48
File Name F:\Leeds Spectra\jdaf26.1\10\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 322.50 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2734.5210 Spectrum Type STANDARD
Sweep Width (Hz) 6510.22 Temperature (degree C) 25.200
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APPENDIX 11.1 – 13C{1H} NMR spectrum of [RuCl(P(i-Bu)3)2(p-cymene)]SbF6 (11) in CDCl3 
 
Acqu is it ion  T ime (s ec ) 0.6980 Comment Name.- Joel Fonseca Room/Lab No.- 1.29 Sample.- JDAF 26.1 RuC l(C12 H27 P )2 C10 H14 SbF6 NMR serv ice
Date 12 Jun 2011 02:44:32 Date  S tamp 12 Jun 2011 02:44:32
F ile  N ame F:\Leeds Spectra\jdaf26_1.INO \10 (jdaf26.1_13C  NMR)\PDATA\1\1r F requency  (MH z ) 125.76 Nuc leus 13C
Number o f T rans ien ts 24576 O rig in drx500 O rig ina l Po in ts  C ount 24576 Owner gen
Poin ts  C ount 131072 Puls e  Sequence zgpg30 Rece iver  G a in 9195.20 SW (cyc lic a l)  (H z ) 35211.27
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APPENDIX 11.2 – 31P{1H} NMR spectrum of [RuCl(P(i-Bu)3)2(p-cymene)]SbF6 (11) in CDCl3 
 
Acquis ition T ime (sec ) 0.7356 Comment Name.- Joel Fonseca Room/Lab No.- 1.29 Sample.- JDAF 26.1 RuC l(C12 H27 P)2 C10 H14 SbF6 NMR service
Date 13 Jun 2011 06:15:44 Date  S tamp 13 Jun 2011 06:15:44
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APPENDIX 12 – 1H NMR spectrum of [RuCl2P(i-Bu)3(p-cymene)] (12) in CDCl3 
 
Acquisition Time (sec) 5.2953 Comment Name- Joel Fonseca Room No- 1.29 Sample- jdaf27pp Date 15 Jun 2011 17:14:56
Date Stamp 15 Jun 2011 17:14:56 File Name F:\Leeds Spectra\jdaf27pp\10\PDATA\1\1r
Frequency (MHz) 300.13 Nucleus 1H Number of Transients 32 Origin spect
Original Points Count 32768 Owner nmr Points Count 65536 Pulse Sequence zg30
Receiver Gain 228.00 SW(cyclical) (Hz) 6188.12 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1847.1880 Spectrum Type STANDARD Sweep Width (Hz) 6188.02 Temperature (degree C) 26.875
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APPENDIX 12.1 – Mass spectrum of [RuCl2P(i-Bu)3(p-cymene)] (12) 
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APPENDIX 13 – 1H NMR spectrum of [RuCl2P(n-Bu)3(p-cymene)] (13) in CDCl3 
 
Acquisition Time (sec) 5.2953 Comment Name- Joel Fonseca Room No- 1.29 Sample- jdaf33 Date 24 Jun 2011 17:25:36
Date Stamp 24 Jun 2011 17:25:36 File Name F:\Leeds Spectra\jdaf33\10\PDATA\1\1r
Frequency (MHz) 300.13 Nucleus 1H Number of Transients 32 Origin spect
Original Points Count 32768 Owner nmr Points Count 65536 Pulse Sequence zg30
Receiver Gain 228.00 SW(cyclical) (Hz) 6188.12 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 1847.2825 Spectrum Type STANDARD Sweep Width (Hz) 6188.02 Temperature (degree C) 27.109
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APPENDIX 14 – 1H NMR spectrum of [RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf28 Date 17 Jun 2011 15:28:16
Date Stamp 17 Jun 2011 15:28:16 File Name F:\Leeds Spectra\jdaf28\10\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 16384 Owner nmr Points Count 32768 Pulse Sequence zg30
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Spectrum Offset (Hz) 2734.1233 Spectrum Type STANDARD Sweep Width (Hz) 6510.22 Temperature (degree C) 25.500
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APPENDIX 14.1 – 31P{1H} NMR spectrum of [RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) in CDCl3 
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Solven t CHLOROFORM-d Spec trum  O ffset (Hz ) -0.0039 Spec trum  Type STANDARD
Sweep W id th  (H z) 49018.86 Temperature (degree C ) 27.021
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APPENDIX 14.2 – Mass spectrum of [RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) 
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APPENDIX 15 – 1H NMR spectrum of [RuCl2PhP(OCH3)2(p-cymene)] (15) in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf30 Date 17 Jun 2011 15:17:36
Date Stamp 17 Jun 2011 15:17:36 File Name F:\Leeds Spectra\jdaf30\10\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 16384 Owner nmr Points Count 32768 Pulse Sequence zg30
Receiver Gain 574.70 SW(cyclical) (Hz) 6510.42 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2736.2866 Spectrum Type STANDARD Sweep Width (Hz) 6510.22 Temperature (degree C) 25.500
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APPENDIX 15.1 – Mass spectrum of [RuCl2PhP(OCH3)2(p-cymene)] (15) 
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APPENDIX 16 – [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) Crystal Data 
Formula C152H111Cl6F12N4O4P8Ru4Sb2 
Formula weight 3393.69 
Size 0.22 x 0.15 x 0.07 mm 
Crystal morphology Brown Fragment 
Temperature 150(2) K 
Wavelength 0.71073 Å  [Mo-Kα] 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 27.319(3) Å α = 90° 
 b = 18.239(2) Å β = 96.207(6)° 
 c = 33.008(4) Å γ = 90° 
Volume 16351(3) Å3 
Z 4 
Density (calculated) 1.379 Mg/m3 
Absorption coefficient 0.925 mm-1 
F(000) 6764 
Data collection range 1.34 ≤ θ ≤ 30.34° 
Index ranges -38 ≤ h ≤35,  -25 ≤ k ≤ 24,  -43 ≤ l ≤ 46 
Reflections collected 329686 
Independent reflections 48605 [R(int) = 0.1824] 
Observed reflections 19785 [I >2σ(I)] 
Absorption correction multi-scan 
Max. and min. transmission 0.9374 and 0.8195 
Refinement method Full 
Data / restraints / parameters 48605 / 0 / 1720 
Goodness of fit 1.033 
Final R indices  [I >2σ(I)] R1 = 0.1029, wR2 = 0.2845 
R indices (all data) R1 = 0.2466, wR2 = 0.375 
Largest diff. peak and hole 5.371 and -2.638e.Å-3 
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APPENDIX 17 – Labelled molecular structure of 
[Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) 
 
 
 
 
 
APPENDIX 18 – Selected Bond Lengths (Å) and Angles (deg) for 
[Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) obtained by X-ray 
crystallography. 
Bond Distances 
Ru(1)-P(15) 2.326(3) Ru(1)-Cl(7) 2.513(2) 
Ru(1)-P(19) 2.304(3) Ru(1)-Cl(9) 2.520(2) 
Ru(2)-P(10) 2.318(3) Ru(1)-Cl(13) 2.428(3) 
Ru(2)-P(11) 2.318(3) Ru(2)-Cl(7) 2.492(2) 
Ru(1)-N(2) 2.007(5) Ru(2)-Cl(9) 2.418(2) 
Ru(2)-N(5) 2.020(5) Ru(2)-Cl(13) 2.497(2) 
Bond Angles 
P(15)-Ru(1)-Cl(7) 174.74(9) P(19)-Ru(1)-Cl(13) 98.81(9) 
P(15)-Ru(1)-Cl(9) 97.07(8) N(2)-Ru(1)-Cl(7) 94.05(14) 
P(15)-Ru(1)-Cl(13) 95.25(9) N(2)-Ru(1)-Cl(9) 89.89(14) 
P(19)-Ru(1)-Cl(7) 86.07(8) N(2)-Ru(1)-Cl(13) 168.56(14) 
P(19)-Ru(1)-Cl(9) 165.97(9)   
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APPENDIX 19 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl2(p-cymene)]2 (1)-dppf as pre-
catalyst (S/C=20), in CDCl3 
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APPENDIX 20 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl2(p-cymene)]2 (1)-DPEPhos as 
pre-catalyst (S/C=20), in CDCl3 
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APPENDIX 21 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl2(p-cymene)]2 (1)-dippf as pre-
catalyst (S/C=20), in CDCl3 
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APPENDIX 22 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl2(p-cymene)]2 (1)-P(i-Bu)3 as 
pre-catalyst (S/C=20), in CDCl3 
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APPENDIX 23 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuI2(p-cymene)]2 (2)-dppf as pre-
catalyst (S/C=20), in CDCl3 
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APPENDIX 24 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuI2(p-cymene)]2 (2)-DPEPhos as 
pre-catalyst (S/C=20), in CDCl3 
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APPENDIX 25 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuI2(p-cymene)]2 (2)-dippf as pre-
catalyst (S/C=20), in CDCl3 
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APPENDIX 26 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl(dppf)(p-cymene)]SbF6 (4) as 
pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 27 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl(dppf)(p-cymene)]BF4 (6) as 
pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 28 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl(dppf)(p-cymene)]BF4 (6) as 
pre-catalyst (S/C=20), in CDCl3 
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APPENDIX 29 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl(dppf)(p-cymene)]Cl (7) as 
pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 30 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl(dppf)(p-cymene)]Cl (7) as 
pre-catalyst (S/C=20), in CDCl3 
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APPENDIX 31 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuI(dppf)(p-cymene)]SbF6 (5) as 
pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 32 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) 
as pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 33 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) 
as pre-catalyst (S/C=40), in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf34 Date 28 Jun 2011 18:08:16
Date Stamp 28 Jun 2011 18:08:16 File Name F:\Leeds Spectra\jdaf34\10\PDATA\1\1r
Frequency (MHz) 500.23 Nucleus 1H Number of Transients 32 Origin avance500
Original Points Count 16384 Owner nmr Points Count 32768 Pulse Sequence zg30
Receiver Gain 90.50 SW(cyclical) (Hz) 6510.42 Solvent CHLOROFORM-d
Spectrum Offset (Hz) 2694.6929 Spectrum Type STANDARD Sweep Width (Hz) 6510.22 Temperature (degree C) 23.800
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
or
m
al
iz
ed
 
In
te
n
si
ty
2.000.01
 
APPENDIX 34 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl(P(i-Bu)3)2(p-cymene)]SbF6 
(11) as pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 35 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl2(P(n-Bu)3)2(p-cymene)] (13) 
as pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 36 – 1H NMR spectrum of the product from the N-
alkylation of t-butylamine using [RuCl(P(CH3)3)2(p-cymene)]SbF6 (14) 
as pre-catalyst (S/C=40), in CDCl3 
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APPENDIX 37 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuCl2(p-cymene)]2 (1) as pre-catalyst, in 
CDCl3 
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APPENDIX 38 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuCl2(p-cymene)]2 (1)-dppf as pre-catalyst, 
in CDCl3 
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APPENDIX 39 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuCl2(p-cymene)]2 (1)-DPEPhos as pre-
catalyst, in CDCl3 
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APPENDIX 40 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuCl2(p-cymene)]2 (1)-dippf as pre-catalyst, 
in CDCl3 
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APPENDIX 41 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuI2(p-cymene)]2 (2) as pre-catalyst, in 
CDCl3 
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APPENDIX 42 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuI2(p-cymene)]2 (2)-dppf as pre-catalyst, in 
CDCl3 
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APPENDIX 43 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuI2(p-cymene)]2 (2)-DPEPhos as pre-
catalyst, in CDCl3 
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APPENDIX 44 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuI2(p-cymene)]2 (2)-dippf as pre-catalyst, 
in CDCl3 
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APPENDIX 45 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuCl(dppf)(p-cymene)]Cl (7) as pre-catalyst, 
in CDCl3 
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APPENDIX 46 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) as pre-
catalyst, in CDCl3 
 
Acquisition Time (sec) 2.5166 Comment Full Name -  Joel Fonseca Room No. -  1.29 Sample -  jdaf58
Date 22 Jul 2011 21:30:56 Date Stamp 22 Jul 2011 21:30:56
File Name F:\Leeds Spectra\jdaf58\10\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 71.80 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2752.8691 Spectrum Type STANDARD
Sweep Width (Hz) 6510.22 Temperature (degree C) 27.000
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
No
rm
a
liz
e
d 
In
te
n
sit
y
0.103.00
 
p-Cymene Based Ruthenium Complexes as Catalysts 
 
kkk 
Joel David Avelino Fonseca 
APPENDIX 47 – 1H NMR spectrum of the product from the reduction 
of acetophenone using [Ru2Cl3(DPEPhos)2(CH3CN)2]SbF6 (8) as pre-
catalyst, in CDCl3 
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APPENDIX 48 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuCl2(p-cymene)]2 (1) as pre-catalyst, in 
CDCl3 
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APPENDIX 49 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuCl2(p-cymene)]2 (1)-dppf as pre-catalyst, 
in CDCl3 
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Date 29 Jul 2011 17:57:36 Date Stamp 29 Jul 2011 17:57:36
File Name F:\Leeds Spectra\jdaf67\10\PDATA\1\1r Frequency (MHz) 500.23 Nucleus 1H
Number of Transients 32 Origin avance500 Original Points Count 16384 Owner nmr
Points Count 32768 Pulse Sequence zg30 Receiver Gain 71.80 SW(cyclical) (Hz) 6510.42
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2735.1577 Spectrum Type STANDARD
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APPENDIX 50 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuCl2(p-cymene)]2 (1)-DPEPhos as pre-
catalyst, in CDCl3 
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APPENDIX 51 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuCl2(p-cymene)]2 (1)-dippf as pre-catalyst, 
in CDCl3 
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APPENDIX 52 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuI2(p-cymene)]2 (2) as pre-catalyst, in 
CDCl3 
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APPENDIX 53 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuI2(p-cymene)]2 (2)-dppf as pre-catalyst, in 
CDCl3 
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APPENDIX 54 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuI2(p-cymene)]2 (2)-DPEPhos as pre-
catalyst, in CDCl3 
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APPENDIX 55 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuCl(dppf)(p-cymene)]Cl (7) as pre-catalyst, 
in CDCl3 
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Receiver Gain 114.00 SW(cyclical) (Hz) 6510.42 Solvent CHLOROFORM-d
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APPENDIX 56 – 1H NMR spectrum of the product from the reduction 
of benzaldehyde using [RuI(P(n-Bu)3)2(p-cymene)]SbF6 (10) as pre-
catalyst, in CDCl3 
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Sweep Width (Hz) 6510.22 Temperature (degree C) 27.000
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